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ABSTRACT 
 
In 2008, 1.8 million children under the age of 15 were living with HIV/AIDS in 
sub-Saharan Africa. The same report estimates that in 2008, there were 390 000 
new infections in children below the age of 15 in Sub- Saharan Africa. Children 
appear to be the generation most affected by the HIV/AIDS epidemic. With the 
introduction of Highly Active Antiretroviral therapy (HAART) more perinatally 
infected children are living into adolescence and beyond. They will have to learn 
to live with a stigmatising, potentially fatal chronic illness. 
 
Health care workers can no longer rely solely on traditionally used outcome 
measures, such as viral loads and CD4+ percentages, to monitor effectiveness of 
interventions and treatments. Quality of Life (QoL) has been suggested as an 
additional essential outcome measure in clinical practice and research involving 
children living with a chronic illness. In this research the concept of Health 
Related Quality of Life (HRQoL) is evaluated in HIV-infected children using the 
PedsQL 4.0 Generic Core Scale (child self-reports, ages five-seven). The 
PedsQL 4.0 Generic Core Scales has been found to be a valid and reliable 
HRQoL measurement tool in children with chronic diseases, school-going 
children and children infected with HIV. 
 
 Domains of Physical, Emotional, Social and School Functioning were evaluated. 
The children in the comparison group scored significantly higher (p<0.01) 
indicating a better quality of life. The HIV-infected children scored significantly 
lower in all four domains, with Physical Functioning being most affected (p<0.01). 
The children with HIV were found to be shorter (p<0.01) and lighter (p<0.01) than 
those in the comparison group. This could be a contributing factor to the physical 
difficulties experienced by the HIV-infected children. No relationship could be 
established between total scores of HRQoL and CD4+ percentages, viral load 
and duration of HAART treatment. 
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Demographic data collected indicate that the HIV-infected children were more 
likely to have a primary caregiver with a lower level of education (p=0.01) and 
more likely to be receiving a Dependency Care Grant (p=0.05). 
  
The HRQoL results of this study are similar to those conducted in other parts of 
the world. The results stress the need for a multi-disciplinary approach when 
treating HIV-infected children. It has become essential to focus on the medical, 
physical and psychosocial functioning of the HIV-infected child thereby promoting 
participation in the family, school and the broader community.   
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Chapter 1: INTRODUCTION 
 
 According to the 2009 UNAIDS Report, in Sub- Sahara Region, 1.8 million 
children under the age of 15 were living with HIV/AIDS in 2008. The same report 
estimates that in 2008, there were 390 000 new infections in children below the 
age of 15 in Sub- Saharan Africa (UNAIDS, 2009). By 2010, it has been 
predicted that 15.7 million children in sub- Sahara Africa (SSA) would have lost 
at least one parent (Chandan and Richter, 2009). In sub-Saharan Africa, children 
appear to be the generation most affected by the HIV/AIDS epidemic (Earls et al, 
2009). The United Nations Convention on Children’s Rights (United Nations, 
1998) states that each child has the right to a standard of health and living that 
would maximise his/her physical, mental, spiritual and social potential. With the 
introduction of Highly Active Antiretroviral therapy (HAART) more perinatally 
infected children are living into adolescence and beyond (UNAIDS/WHO, 2006). 
They will have to learn to live with a stigmatising, potentially fatal chronic illness 
(Mellins et al 2002). 
  
HIV/AIDS, in the child population, has been associated with developmental 
delay, growth disturbances, cognitive and psychological problems (Richter, 
2004). Since the introduction of HAART, the incidence of severe HIV 
encephalopathy has decreased (Patel et al, 2009; Mitchell, 2006) however 
HAART has not been as effective in reducing the more subtle forms of 
encephalopathy (Mitchell, 2006).  Despite HAART, children have been shown to 
display developmental delay and cognitive impairment (Smith, 2008; Mitchell, 
2006). In sub- Saharan Africa despite only 15% of children requiring ARV therapy 
being treated (UNAIDS 2007), many children are living into adolescence. 
 
An increased rate of psychiatric problems has been associated with children 
suffering from any chronic condition (Scharko, 2006). Anxiety, depression and 
attention deficit hyperactivity disorder (ADHD) have all been shown to be 
common amongst children with HIV/AIDS (Scharko, 2006).  
2 | P a g e  
 
 
As HIV/AIDS is now considered to be a chronic condition and children have 
access to more effective clinical interventions and longer life expectancy, we can 
no longer rely solely on traditionally used outcome measures, such as viral loads 
and CD4+ percentages, to monitor effectiveness of interventions and of 
treatments (Garvie et al, 2009; Lee et al, 2006; Missmer et al, 2000). An 
additional health measure, Quality of Life (QoL), has been suggested to evaluate 
outcomes for children with chronic health conditions (Lee et al, 2006; Missmer et 
al, 2000; Wallender and Varni, 1998). 
 
Quality of Life (QoL) has been defined by the WHO as “the individual’s 
perception of their position in life in the context of culture and value systems in 
which they live, and in relation to their goals, expectations, standards, and 
concerns.” (WHOQOL, 1997. Page1). According to Wallender et al (2001) the 
concept of HRQoL is a narrower approach, as it looks at QoL purely in the 
medical context, however overall QoL incorporates influences on school, family, 
friends and other living circumstances.  It appears in the literature that the terms 
HRQoL and QoL are terms that are often used interchangeably (Eiser and 
Morse, 2001; Wallender and Varni, 1998) and no consensus has been found on 
the use of the two terms (De Civita et al, 2005). 
 
Research into HRQoL and HIV has focused more on the adult population (Garvie 
et al, 2009).Despite the limited research , it is becoming evident that HIV/AIDS 
has a negative impact on the QoL of paediatric patients with  HIV (Banerjee et al, 
2010; Bomba et al, 2010; Xu et al, 2010; Oberdorfer et al, 2008; Lee et al, 2006; 
Storm et al, 2005).Some of the factors that may affect health-related quality of life 
(HRQoL) of children living with HIV/AIDS include – stigma associated with the 
disease, altered family dynamics, poor access to medical care, poor nutrition, 
and medication with toxic side effects and (Missmer et al, 2000). 
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The majority of tools that have been used to assess QoL in patients with 
HIV/AIDS have focused on adults rather than the paediatric community (Clayson 
et al, 2006; Berzon and Lenderking, 1998; Shumaker, 1997; Hays and Shapiro, 
1992). In a review by Clayson et al (2006), 17 generic and 17 HIV specific tools 
were assessed. He was however unable to recommend any one of the tools as 
being the most effective excluding measures due to their extensive length, lack of 
normative data, insufficient content to comprehensively assess HRQoL and 
excessive administration. Excessive administration was not qualified in the 
report. 
 
The PedsQL 4.0 Generic Core Scales (Paediatric Quality of Life Inventory) is a 
brief, standardised generic assessment instrument that systematically assesses 
patients’ and parents’ perceptions of HRQoL in paediatric patients with chronic 
health conditions (Varni et al, 1999). The measurement tool is designed to 
measure the core health dimensions delineated by the WHO namely- physical 
functioning (eight items), emotional functioning (five items), social (five items) 
and school functioning (five items) (Varni et al, 2001). The PedsQL 4.0 Generic 
Core Scales are comprised of parallel child self-report for ages five-18 and 
parent proxy- report for ages two -18. (Varni et al, 2006). The necessity of using 
child self-reporting in measuring QoL has been stressed in the literature 
(Rosenbaum, 2008; Eiser and Morse, 2001). The PedsQL4.0 Generic Core 
Scales have been used in research to assess the health- related quality of life of 
HIV infected children (Banerjee et al, 2010; Bomba et al, 2010; Xu et al, 2010). 
 
Problem statement 
Since the introduction of HAART in South Africa in 2004, the life expectancy of 
children infected with HIV has increased. It is however important to be able to 
assess whether this increase in life expectancy is accompanied by a decrease in 
the quality of life of these children. There are many additional factors, in the 
South African context, which may affect the quality of life of children in addition to 
HIV/AIDS.  
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Significance of study 
A search of the literature has shown that there has been very limited research on 
the HRQoL of children infected with HIV/AIDS in South Africa. The information 
gathered on the quality of life of children with HIV/AIDS would be of benefit to all 
the health team members, and family, involved in the treatment of young children 
with HIV/AIDS. The information would assist in determining the resource 
allocation that is necessary in terms of social, emotional and school support that 
would optimise the quality of life of the children with HIV/AIDS. In addition, the 
specific domains assessed using the PedsQL 4.0 Generic Core Scales may 
highlight specific aspects of quality of life that are consistently affected by the 
disease process that need specific intervention and considerations when treating 
a child with HIV/AIDS holistically. 
 
Aims of the study 
 To assess and evaluate  the quality of life of children infected with HIV 
using the PedsQL 4.0 Generic Core Scales 
 
Objectives of the study 
 To determine if any specific domain/s assessed in the Generic PedsQL 
4.0 Core Scale is more affected in children with HIV/AIDS. 
 To determine if there is a relationship between socio-economic factors and 
quality of life using the HESSI Questionnaire  
 To determine if there is a correlation between health status (CD4 count, 
viral load and antiretroviral therapy) and quality of life 
  To compare quality of life of children with HIV/AIDS, using the PedsQL 
4.0 Generic Core Scale, to children uninfected with HIV/AIDS. 
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Chapter 2: LITERATURE REVIEW 
 
 
With the introduction of highly active antiretroviral therapy (HAART) in the mid 
1990s, the life expectancy of children with HIV/AIDS has increased, thus HIV can 
now be considered as a chronic medical condition (Garvie et al, 2009; Lee et al 
2006; Missmer et al, 2000).  It has therefore become increasingly important to 
study the quality of life of children living with HIV/AIDS (Garvie et al, 2009). Using 
quality of life as a research outcome, we are able to assess the effectiveness of 
treatments and services on the paediatric population (Missmer et al, 2000). 
   
This literature review serves to discuss the concepts of quality of life (QoL) and 
health related quality of life (HRQoL) as well as the factors that impact on the 
quality of life of children living with HIV/AIDS. Key concepts to be discussed 
include vertical transmission of HIV, classification of disease stages, specific 
applicable manifestations of HIV in the paediatric and school- aged population, 
psychosocial adjustment and the psychosocial effects of HIV/AIDS. Articles were 
found searching Pubmed, Medline and Psychiatry online. A hand search was 
conducted in the Health Sciences Library at the University of the Witwatersrand. 
 
2.1 Introduction 
In Africa, both HIV-1 and HIV-2 have been identified. HIV-2 is found mainly in 
western African countries and appears to be less virulent than HIV-1 (Zeichner, 
2006). For the purposes of this research, HIV-1, found in South Africa, will be 
referred to as HIV. 
  
In November 2003 the South African government introduced the Comprehensive 
HIV and AIDS Care, Management and Treatment Plan (South African 
Government Task Team, 2003), with the national roll-out of HAART beginning in 
March 2004 (Meyers et al, 2007). As a result the number of children receiving 
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highly active antiretroviral therapy (HAART) has increased from less than 3000 in 
2005 to more than 21 000 in September 2006 (Meyers et al, 2007). However by 
the end of 2008, the World Health Organisation estimated that there were 94 000 
children living in South Africa that required HAART (WHO Progress report, 
2009). With the introduction of HAART we have seen a decrease in mortality and 
morbidity rate in children living with HIV/AIDS (Patel et al 2009; Lee, 2006; 
Gortmaker et al, 2001). Challenges facing HIV-infected children and their health 
care providers, at present and in the future, will include associated disabilities, 
adherence to HAART, disclosure and changing life circumstances (Brown et al, 
2010; Lee et al, 2006)  
 
 The concept of a chronic childhood disease requires defining so as to ascertain 
the applicability of the term with reference to HIV/AIDS. Mokkink et al, (2008), 
defined a childhood chronic disease using four criteria namely: (1) child must be 
aged younger than 18; (2) the diagnosis is made using scientific knowledge and 
is reproducible using valid methods and instruments; (3) the disease is 
considered not curable at time of diagnosis; (4) the condition has been present 
for more than three months or expected to be so. The above definition reflects 
only on the medical aspects of a condition without looking at the broader impact 
a disease might have on a child. This was included in a definition by Perrin et al 
(1993) who looked at the level of functional impairment associated with a disease 
or condition and the amount of medical care required ( more than expected for a 
child of a certain age) .  From the above two definitions it is valid to say that 
HIV/AIDS can be considered a chronic childhood condition/disease.  
 
In the following paragraphs, mother-to child transmission, classification of HIV, 
HAART, adherence, and growth patterns associated with HIV will be discussed. 
These topics have been chosen for their relevance to the research.  
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2.2 Mother- to Child Transmission and Diagnosis of HIV in Young Children 
 In South Africa women of child-bearing age (15-29) have the highest rates of 
HIV infection (Karim et al, 2008). More than 90% of paediatric infection is through 
vertical transmission (WHO Progress Report, 2009; Lourie et al, 2005). It has 
been suggested that mother-to child transmission (MTCT) can occur in utero, 
intra-partum (80%), and through breastfeeding (Sturt et al, 2010; Read, 2005). 
There are various risk factors that have been identified as increasing the risk of 
MTCT. These include increased mother’s viral load, increased duration of 
exposure especially with ruptured membranes, breastfeeding, mixed 
breastfeeding and maternal vitamin A deficiency (Read, 2005). Vertical 
transmission rates, without preventative intervention, have been shown to be 
between 25-48% in resource-poor, breastfeeding populations and 14-23% in 
industrialised, non- breastfeeding populations (Gray and McIntyre, 2007; De 
Cock, 2000). A transmission rate as low as two percent has also been reported in 
developed countries. This is with the intervention of antiretroviral therapy, 
caesarean sections and formula feeding. However in most highly affected 
countries, preventative measures have only managed a 15 percent reduction in 
transmission (Gray and McIntyre, 2007). In sub- Saharan Africa, where over 85% 
of all HIV-infected women are found, only 11% have access to preventative 
mother-to child transmission interventions (UNAIDS/UNICEF 2007). Since the 
introduction of MTCT intervention measures in South Africa, we are still unable to 
assess the efficacy of the programmes or the extent of the efficacy (Meyers et al, 
2007). 
 
The clinical diagnosis of HIV infection in children older than 18 months is 
confirmed with two positive rapid tests. If one of the rapid tests is negative,a 
confirmatory enzyme-linked immunosorbent assay (ELISA) test is indicated. In 
children younger than 18 months a positive HIV DNA polymerase chain reaction 
test (PCR) together with a confirmatory viral detection assay is required to 
positively diagnose HIV. The baseline viral load would have to be above 10 000 
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copies/mL (National Department of Health, 2010) . With HIV infection both the 
cell mediated and humoral immune functions of the child are compromised.  
 
According to McFarland (2005), the defining characteristic of HIV, if left 
untreated, is the continuous reduction of absolute numbers and percentage of 
CD4+ T lymphocytes of the total lymphocyte count. The risk of opportunistic 
infections is indirectly proportional to the amount of CD4+ T lymphocytes present 
in the child’s system (McFarland, 2005). According to Coovadia and Wittenberg 
(2007), the measure of the viral load (HIV-RNA copy number) in the infant is of 
importance as it offers us a prognostic value i.e. the higher the viral load the 
more rapid the disease progression.  However McFarland (2005) states that 
CD4+ percentage is a more reliable indicator of disease progression. There is an 
inverse, but variable, correlation between plasma RNA and the level of CD4+ 
lymphocytes (McFarland, 2005). With the use of HAART, we see an increase in 
CD4+ number and a decrease in plasma RNA. According to the classification 
system introduced by The Centers for Disease Control and Prevention in 1994, 
children between the ages of six and 12 years, with a CD4+ count of greater or 
equal to 25%, show no evidence of immune suppression. 
 
2.3 Classification of Paediatric HIV Infection 
The Centre for Disease Control and Prevention (1994) established a 
classification system for children with HIV based on their clinical and 
immunologic status.  The clinical classification consists of four groups: stage N- 
no signs and symptoms; stage A- mild signs and symptoms (examples 
hepatomegaly, splenomegaly, lymphadenopathy, and recurrent otitis media); 
stage B- moderate signs or symptoms (lymphoid interstitial pneumonitis is the  
only AIDS defining illness included in this category); stage C- severe signs and 
symptoms ( including all other AIDS defining conditions). It has been noted that 
some children can pass from stage N to stage C directly. 
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 The WHO (2007) has implemented its own classification system, similar to that 
of the Centre for Disease Control, with children classified by Clinical Stages One 
to Four. Stage 1 indicates no symptoms present; stage 2: mild symptoms 
present; stage 3: child displays advanced symptoms and stage 4: child displays 
severe symptoms. The medical conditions associated with each stage are 
extensive (WHO, 2007).   
 
Immunological status has been described by the Centre for disease control 
(CDC, 1994). This is described in the table below: 
 
 Immunologic categories based on age-specific CD4+ T-lymphocyte counts 
 and percent of total lymphocytes 
                                            Age of child 
                               ------------------------------------------------------ 
                                                          <12 mos             1-5 yrs                   6-12 yrs 
                               ----------------    ----------------          ------------                ------------------------------ 
           Immunologic category             uL      (%)         uL      (%)                uL      (%) 
------------------------------------------------------------------------------------------------------------------------------ 
1: No evidence of suppression  >=1,500  (>=25)       >=1,000  (>=25)     >=500  (>=25) 
 
2: Evidence of moderate           750-                             500-                        200- 
   suppression                           1,499  (15-24)                999  (15-24)            499  (15-24) 
 
3: Severe suppression            <750    (<15)                <500   (<15)              <200    (<15) 
 
 
2.4 Highly Active Antiretroviral Therapy 
The goals of HAART in paediatric patients with HIV are fourfold: to achieve viral 
suppression; restore or preserve immunological function; sustained improvement 
in clinical symptoms and reduction in morbidity and mortality and consequently 
improve quality of life (Cotton et al, 2009; Havens, 2003). Without HAART 
intervention, the large majority of infected children would die before their fifth 
birthday (Newell et al, 2004). A combination of three or more antiretroviral 
medications has been recommended replacing the original monotherapy 
previously advocated (Havens, 2003).  All infants younger than twelve months 
should receive HAART irrespective of immunological status (Cotton et al, 2009). 
This is to reduce the rates of encephalopathy and rapid disease progression 
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(Havens et al, 2003). Babies older than twelve months should begin HAART 
even with mild symptoms associated with HIV( Category A on CDC classification) 
(Havens, 2003).The benefits and guidelines regarding the initiation of HAART 
based on CD4 levels only, in an asymptomatic child, remains inconclusive 
(Havens, 2003).  In sub-Saharan Africa, since 2003, coverage of HAART has 
improved from only 2% to 40% (Harries et al, 2010). HAART should include 
category II nucleoside reverse transcriptase inhibitors (NRTI) as well as a 
category III non-nucleoside reverse transcriptase inhibitor (NNRTI) (Dep.of 
Health, 2010). Guidelines published in 2010 advocate the initiation of HAART for 
all babies younger than one year, children aged one to five years who are 
symptomatic (stage III or IV) with absolute CD4+ <750 cells/mm³  and those 
older than the age of five who are symptomatic and with absolute CD4+ <350 
cells/mm³ (Dep. of Health, 2010). Preferred regimen for children younger than 
three or weighing less than 10 kg is Abacavir, Lamivudine and 
Lopinavir/Ritonavir. For chlidren older than three and weighing more than 10 kg, 
Abacavir, Lamivudine and Efavirez is preferred (Dep. of Health, 2010). 
 
Despite the significant decrease in mortality, morbidity and hospitalization rates 
seen with the use of HAART in paediatric patients (Gortmaker et al, 2001), this 
comes at a cost of a plethora of side effects associated with antiretroviral 
medication use (Brown et al, 2010; Cotton et al, 2009; Aldrovandi, 2005; 
McKinney, 2005; Havens, 2003). These include: hematological (anemia and 
neutropenia), gastrointestinal (diarrhea, vomiting, nausea), myopathies, 
neuropathies, hyper pigmentation, fatigue, hepatitis and skin rashes (McKinney, 
2005). Lipodystrophy has also been reported (Cotton et al, 2009). The extensive 
short- and- long term side effects noted with HAART, has raised the issue of 
replacing the morbidities associated with immuno-suppression with those 
associated with antiretroviral toxicity (Aldrovandi, 2005). Non-adherence to 
HAART and the consequent emergence of a drug-resistant HIV strain and a 
detectable viremia remains a challenge to health workers and patient alike 
(Brown et al, 2010; Havens, 2003). 
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2.5 Adherence to HAART in Paediatric Patients 
Adherence to HAART remains a challenge for HIV-infected adults, children and 
their health workers. In a review of studies analyzing adherence of paediatric 
patients to HAART, Mellins et al (2004) found that rates of adherence ranged 
from 57 to 81%.  These rates of adherence are not conducive to long-term viral 
suppression and treatment (Mellins, 2004). 
 
 Looking at sub-Saharan Africa specifically, in relation to adherence success, 
data was found relating to adult adherence. Rosen et al (2007) in their literature 
review found that only 60% of adults continued with their antiretroviral medication 
longer than 2 years after initiating therapy. The main causes of non- adherence 
cited included death and loss to follow –up. In research conducted in the Eastern 
Cape region of South Africa, using adults living in rural and urban environments, 
barriers to adherence were found to be social stigma, amount of support from 
family and friends, accessibility to medication and long standing racial 
misconceptions from the apartheid era (Mitchell et al, 2009). In the National 
Antiretroviral Treatment Guidelines (Department of Health, 2010), both medical 
and psychosocial criteria are specified for eligibility of antiretroviral therapy for 
children and adults. The caregiver/parent has to demonstrate reliability by 
attending clinics regularly and should have a support network in place including 
another adult who is aware of the child’s HIV status.  
 
From the research, a picture is emerging as to the barriers of effective paediatric 
adherence. Levels of adherence are not only influenced by the child and his/her 
immediate environment but also factors that are beyond their control. The use of 
HAART introduces a life- long daily use of multiple, often unpalatable, 
medications administered at required specific times. The medications require 
specific storage requirements and precise dosage. In addition to this are the 
many previously mentioned long-term and short-term side effects associated with 
12 | P a g e  
 
the use of HAART. These factors in themselves form a barrier to effective 
adherence (Simoni et al, 2007; Steele et al, 2007; Mullen et al, 2002). 
 
For some patients access to health services to obtain the medication remains 
difficult from an economic perspective and distance required to travel to clinics. 
The health-care workers themselves may create a barrier if they are poorly 
trained and have ineffective communication skills with the children and caregiver 
(Simoni et al, 2007). Neglecting to take into account the belief and cultural norms 
of the child and his/her family, will influence patterns of adherence (Steele et al, 
2007). Payment for therapy and its effect on adherence was analysed in 
Biadgilign et al (2008) who found that adherence amongst their cohort in Ethiopia 
decreased if the medications were obtained for free. 
 
 Due to the reliance of the younger child on a parent or caregiver for medication, 
family/caregiver factors are crucial to adherence success (Simoni et al, 2007; 
Steele et al, 2007; Mellins et al, 2004). Numerous familial and social factors have 
been shown to influence adherence. Decreased  caregiver quality of life, 
increased stress experienced by child and caregiver,  limited  social support and 
lower family socio-economic status and stability all affect adherence negatively  
(Simoni et al, 2007; Steele et al, 2007; Mellins et al, 2004). A positive relationship 
with good communication between child and caregiver responsible for 
administration of HAART will improve rates of adherence (Steele et al, 2007). As 
HIV encephalopathy and cognitive impairment are still features associated with 
HIV, despite HAART, Malee et al (2009) set out to assess the impact cognitive 
functioning has on adherence. Impaired cognitive functioning in the child does 
not appear to influence rates of adherence (Malee et al, 2009) 
 
Disclosure and its effect on adherence remain inconclusive in the literature. 
Steele et al, 2007 report that non-disclosure affects adherence negatively. 
However further research remains to be done in developing world environment 
where disclosure appeared to decrease adherence in a cohort in Ethiopia 
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(Biadgilign, 2008). This research also indicated the negative impact on 
adherence when the child became aware of his caregiver’s positive HIV status. 
Disclosure will be referred to, in greater detail later in the literature review. 
Demographic data such as caregiver education and caregiver marital status are 
not predictive of adherence or non-adherence (Mellins et al, 2004). 
 
2.6 HIV Related Central Nervous System Disease in Children and 
Associated Motor and Cognitive Development 
The central nervous system may be affected by the HIV virus directly or 
indirectly. The mechanism of indirect involvement is via opportunistic infections, 
malignancies and cerebrovascular disease (Civitello, 2005). The direct 
neurological and developmental effects of HIV and AIDS in HIV-infected infants 
and children, by the virus crossing the blood-brain barrier, has been described 
extensively in the literature (Mitchell, 2006; Belman, 1992; Epstein et al, 1986).  
Three patterns of HIV- related CNS involvement have been suggested by the 
Working Group of the American Academy of Neurology AIDS Task Force (1991) 
and Wolters and Browers (2005) 
1. HIV-related Encephalopathy 
It is characterised by acquired microcephally, global impairments in 
cognition, language (expressive more than receptive), pyramidal tract motor 
deficits, hypertonicity  (lower limbs affected more than upper limbs), and loss 
of social skills. The encephalopathy has been further categorised into a 
progressive, or a static encephalopathy (Mitchell, 2006; Wolters and 
Browers, 2005; Mitchell, 2001). Progressive encephalopathy was the most 
commonly seen neurological manifestation in the pre-HAART era (Mitchell 
2006) and was often seen as an AIDS defining illness in a large percentage 
of children. With the introduction of HAART, the incidence of severe forms of 
encephalopathy has been reduced (Patel et al, 2009; Mitchell, 2006) 
however HIV infection in-utero still poses a risk of encephalopathy 
development (Bomba et al, 2010). In their study, Patel et al (2009) found a 
decrease in the incidence of encephalopathy by 50% with the use of HAART.   
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By 2007, an UNAIDS progress report for South Africa stated that only  36% 
of children with advanced AIDS living in South Africa were receiving HAART 
(Zanoni, 2009). From this data one can assume that the associated motor 
and cognitive delays associated with encephalopathy are still plaguing the 
sub-Saharan paediatric HIV population. 
2. HIV-Related CNS compromise 
Children included in this category include those with overall cognitive 
functioning within normal limits but at the low range of normal. They may 
display some neurobehavioral limitation but are still able to cope in the 
mainstream school environment and with daily activities of living. The early 
administration of HAART is associated with the emergence of CNS 
compromise as opposed to the severe forms of encephalopathy noted prior 
to the HAART era (Wolters and Browers, 2005).  HAART has been less 
effective in reducing the more subtle forms of encephalopathy due to the fact 
that viral replication may continue in the central nervous system (Mitchell, 
2006). Research on the effect of HAART on neurodevelopment has focused 
on children below three years of age. However there is a need for more 
research on older children (Earls et al, 2008).  
3. Apparently not affected  
Cognitive functioning is at least within the normal range. No neuro-
behavioural domains appear affected or show signs of deterioration (Wolters 
and Browers, 2005).  
 
Cognitive development refers to the process of reaching developmental 
milestones, language development, intelligence, and emergence of appropriate 
behavioural and socialization skills.  The varied and extensive measurement 
tools used to assess cognitive development may concentrate on different clusters 
of skills (Sherr et al, 2009).  Research pertaining to the cognitive development 
and functioning in children falling into category two and three, i.e. children with 
CNS compromise and apparently not -affected, remains inconclusive. Small 
sample size, inconsistent measurement tools, varying ages of children, stage of 
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disease, inconsistent   HAART regimes, and varied control groups all contribute 
to the complexity of analysis and interpretation of research results (Sherr et al, 
2009; Martin et al, 2006). Furthermore, factors such as poverty, gender, race, 
and exposure to drugs cannot be eliminated as contributing factors to the 
cognitive development in children with HIV (Sherr et al, 2009).  
 
Since the introduction of Intelligence Quotients (IQ) in 1905, they have been 
used and accepted as adequate measures of intelligence and cognitive 
functioning. A Full Scale Intelligence Quotient (FSIQ) of ≥ 90 and ≤ 110 is 
considered average. Children scoring consistently below 70 on the FSIQ are 
considered to have mental retardation (Gillberg, 2006).  
 
In an attempt to analyse the direct effects that HIV might have on cognitive 
development, researchers have attempted to find a link between cognitive 
development and various factors such as disease stage, extent of radiological 
changes and disease progression. Martin et al (2006) found that the majority of 
HIV-infected school-going children, in his sample, were functioning within the 
normal range of average FSIQ, albeit at the lower end of this range. However 
Nozyce et al (2006), using the same measurement tool as Martin et al (2006), 
found that their sample of HIV- infected children functioned at a lower cognitive 
level than that considered normal for the general population.  
 
 Smith et al (2006), were able to link the extent of cognitive deficit to stage of 
disease, whereby it was found that children in category C (according to the CDC 
Classification), had lower overall scores on cognitive testing. Verbal skills, 
perceptual- performance, quantitative abilities and memory were shown to be 
most affected in this cohort of children. They further demonstrated that HIV 
positive children, without an AIDS defining illness (category A or B in CDC 
classification), performed at the same cognitive level as uninfected children of the 
same age.  
 
16 | P a g e  
 
The direct relationship between radiological changes on computerized 
tomography (CT) scans of the central nervous system and cognitive development 
and functioning has been documented by Blanchette (2001) and Martin et al 
(2006). Children with CT scans, identified as within normal limits, performed as 
their non- infected peers, following a normal curve seen in FSIQ. In contrast 
children with mild to moderate changes were functioning cognitively at a lower 
level. The specific domains that were assessed in this research were working 
memory, logical sequencing and planning, attention to visual detail and visual-
spatial organization (Martin et al, 2006).  
 
A direct correlation between CD4+ percentages, viral load and cognitive 
development of children receiving HAART has not been established (Martin et al, 
2006). 
 
The influence of socioeconomic status, race and mode of HIV transmission as 
independent variables, in the cognitive development of HIV-infected children 
needs to be considered. In Martin et al (2006) and Nozyce et al (2006) previously 
mentioned, the majority of the children were from different demographic groups. 
In Martin et al (2006) the majority of the children were white children (54%), 
whereas in Nozyce et al (2006) only 15% of the children were white and the 
majority of the children were African American. However in neither of the 
research projects was socioeconomic status of the sample defined or suggested  
as an influencing factor on cognitive development. No distinction is made on 
mode of HIV infection. 
 
Despite the appearance that many of the school going HIV-infected children are 
functioning within normal limits cognitively, a large percentage of infected 
children might require additional educational and psychological interventional 
resources (Lourie et al, 2005). This might be due to the fact that when assessed 
on individual subtests of cognitive functioning, as opposed to FSIQ, clear deficits, 
as compared to uninfected peers, are recognised (Martin et al, 2006). The benefit 
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of assessing FSIQ only is therefore questionable in the population of HIV-
infected children. 
 
   
The majority of research on the cognitive development in HIV-infected children 
has centred on American children as study participants (Sherr, 2009). The results 
of this research may not be able to be generalised to children living in poorer 
environments and highly endemic regions such as South Africa. In their review of 
the literature pertaining to cognitive and motor development of HIV infected 
children in Sub-Saharan Africa, Abubaker et al (2008) found a lack of relevant 
data pertaining to children over the age of two. Cognitive delay in South African 
HIV-infected children, younger than three, has been demonstrated by Potterton 
et al (2009) and Baillieu and Potterton (2008) using the Bailey Scales of Infant 
Development (2nd edition). The children assessed were HAART naïve but for a 
small number of children in Potterton et al (2009) receiving antiretroviral therapy. 
Further research on cognitive development in South Africa is needed looking at 
the population of children that have received antiretroviral therapy from an early 
age. The early initiation of HAART, preventing an AIDS defining illness, is of 
crucial importance in optimising the cognitive development of children with 
perinatally transmitted HIV (Smith et al, 2006). 
 
There is no data available at present analysing the cognitive development of 
vertically infected school-aged children in South Africa. In a small study from 
Uganda, the cognitive development of HIV infected school-aged children was 
found to be within normal range with respect to the neurological and 
psychometric measures used. These children were all HAART naïve and were 
not exposed to illicit drugs (Bagenda, 2006). However in the review of this study, 
it was noted that only 40% of HIV-infected children survived their fourth birthday, 
suggesting a very limited sample with only the minimally affected children 
remaining in this cohort (Earls et al, 2008).  
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The development of children in high- prevalence countries is already 
compromised by impoverished conditions (Chandan and Richter, 2009; Earls et 
al, 2008), making it harder to assess the extent of the direct effects that HIV 
infection may have on cognitive development.  Factors relating to poverty, that 
have a varying effect on intellectual/ cognitive development in children with HIV, 
include amount of cognitive stimulation in the home, parenting style, physical 
environment, child health at birth, and childhood health (Guo and Mullen Harris, 
2000). Other factors identified by Smith et al (2006) that were associated 
independently with lower cognitive scores in their cohort of children included 
maternal education and child gender. 
 
Gross motor development in HAART naive vertically infected –HIV children, 
proves to be more compromised than their cognitive development (Potterton et 
al, 2009; Baillieu and Potterton, 2008; Drotar et al, 1997). The above mentioned 
authors have attributed the delay to the presence of generalized weakness 
and/or encephalopathy associated with vertically transmitted HIV. These findings 
corresponded to those of Smith et al (2002) who found similar findings in children 
in a developed country environment, indicating that the motor delay is not 
associated with environmental factors but rather the direct effect of HIV infection. 
 
 2.7 Growth Patterns in Children with HIV 
HIV has been associated with negative long-lasting disturbances of height and 
weight in vertically infected children and these two parameters are often used as 
indicators for prognosis (Isanka et al, 2009; The European Collaborative Study, 
2003; Hirschfeld, 1996). This disturbance in growth patterns is found in 
developed and developing countries alike, indicating the direct association 
between HIV infection and growth (Storm et al, 2005). It is more common to find 
children who have a stunted growth pattern (decreased height for age) as 
compared to a pattern of wasting (decreased weight for age) (Isanka et al, 2009; 
Nachman et al, 2005; Hirschfeld, 1996). Growth disturbances can be noted as 
early as three months and continue into childhood, becoming more marked with 
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age. From the age of two years and four years respectively changes in the height 
and weight patterns of HIV-infected children become more obvious. On average 
HIV-infected children, at age ten, were found to be seven kilograms lighter and 
seven and a half centimetres shorter than a control group and the average of the 
general population (European Collaborative Study, 2003). In the analysis of 
growth disturbances in HIV-infected children it is necessary to eliminate 
socioeconomic factors as a confounding factor. This was achieved by The 
European Collaborative Study using a control group of children born to a HIV 
positive mother but uninfected. These children were found to have no difference 
in growth patterns to the national average for children living in Britain. Additional 
information garnered from this study included the finding that HIV- infected 
children in category C (CDC classification system) appeared to have more 
marked growth disturbances than those children in category A and B. 
 
 Several causes have been proposed for the poor growth namely: (1) repeated 
infections associated with HIV/AIDS, (2) insufficient caloric intake usually due to 
socioeconomic reasons, (3) decreased absorption of food in the gastro-intestinal 
tract and (4) increased energy utilization during HIV replication process (Kabue 
et al, 2008).  This would account for the fact that growth disturbances have been 
noted in children from both developed and less developed countries (Isanka et al, 
2009).  
 
HAART has been shown to have a positive effect on growth dysfunction, with 
both parameters increasing even in a resource poor setting like Uganda (Kabue 
et al, 2008; Nachman et al 2005).  Nachman et al (2005) have noted that the 
positive effects that HAART have on the weight of the child responds quicker 
than the height. Combination therapy appears to have a greater effect on 
improving growth parameters than monotherapy, but more research is required 
to pinpoint the exact regimes which would prove to be more effective (European 
Collaborative Study, 2003).  
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2.8 Psychosocial Well-being and Adjustment of HIV-Infected Children  
For all children, the healthy development of psychological and social functioning 
is influenced by the presence of  a caring and nurturing caregiver, appropriate 
peer relationships, play, schooling and cultural influences (Richter et al, 2006). 
Ultimately children are required to learn the appropriate behaviours and values 
accepted in their communities.  
  
 Chronic paediatric diseases are known to create psychological and social 
burdens on a child and their family (Bauman et al, 1997).  In their definition of 
psychosocial wellbeing of children affected by HIV/AIDS, King et al (2009) look at 
the emotional status of the child, their ability to adjust to their social environment 
and the combination of the two factors. A child infected with HIV, will face many 
social challenges such as illness or death of a parent, stigma, disclosure, 
possible isolation, additional responsibilities in the family, economic constraints 
and the negative side effects of HAART. For that child to be able to adjust and 
fully participate in their family and society, now and in the future, he will require 
the social, emotional, motor and cognitive skills appropriate for his age (King et 
al, 2009; Richter et al, 2006).  The ability of the child to cope and adjust to living 
with a chronic condition becomes vital for his psychosocial well-being. Using the 
definition suggested previously by Wallender and Thompson in 1995, Wallender 
and Varni (1998) described a child to be well adjusted if he displays behaviour 
which is socially acceptable, age appropriate and facilitates future positive adult 
behaviour. Mal-adjustment is associated with clinically pathological and age 
inappropriate behaviour.  
 
In summary, psychosocial adjustment will be influenced by numerous factors. A 
child’s ability to cope and respond positively to high levels of stress will depend 
on temperament, personality type and effectiveness of coping mechanisms 
utilised (Richter, 2004).  Factors, often beyond the control of the child, affecting 
psychosocial adjustment include: medical status, disclosure or non-disclosure, 
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negative life events, availability of social support, familial environment and 
relationships (Steele et al, 2007). In the following paragraphs the author will be 
discussing information relevant to the psychosocial well-being of the child 
infected with HIV. 
 
2. 9 Psychiatric and Behavioural Disorders associated with HIV 
It has been well established that chronic childhood diseases are associated with 
increased, clinically observable, emotional and behavioural problems (Gannoni 
and Shute, 2010; Scharko, 2006). HIV is no exception with the psychological 
effects ranging in severity (Mellins et al, 2003).  Children vertically infected with 
HIV would appear to be at even a greater  risk of developing psychiatric and 
behavioural problems due the effects of the virus crossing the blood-brain barrier,  
potentially neurotoxic antiretroviral medication and growing up in a 
disadvantaged household (Gadow et al, 2010; Nozyce et al, 2006). 
 
Increased levels of anxiety,  depression, attention deficit hyperactivity disorder 
(ADHD) and conduct disorders  have all been observed in the HIV-infected 
paediatric population (Chernoff et al, 2009; Nozyce et al, 2006; Scharko et al, 
2006; Mellins et al 2003). However the direct association between HIV and an 
increase in psychiatric and behavioural problems remains unclear.  Mellins et al 
(2003) and Chernoff et al (2009), from their study comparing HIV infected 
children and a control group (perinatally exposed but uninfected children and 
children living in a house with one infected individual, similar demographic 
characteristics),  found no statistical differences between study and control 
groups with reference to rates of psychiatric and behavioural problems. Both 
groups reported higher incidence of psychiatric and behavioural problems than 
the general population. Mellins et al (2003) argue that it is the demographic 
characteristics and environmental factors associated with the epidemiology of 
paediatric HIV disease that predispose the child to higher than normal levels of 
psychological and behavioural problems (particularly ADHD) - not the HIV 
infection  directly. These factors included family disruption, exposure to poverty, 
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trauma, ongoing parental drug abuse and familial mental illness in the home. In 
this research no mention was made of whether children were receiving HAART 
or at what stage of the disease process they had been classified.  
 
In his review of the literature pertaining to rates of behavioural and psychiatric 
conditions in HIV-infected children, Scharko (2006),  noted the small samples of 
children used in research studies, the variance in ages and mode of infection 
(boys with haemophilia used), and the lack of adequate controls . These 
limitations in studies were addressed by Gadow et al (2010). In their study of 319 
HIV positive children, age, medical status and HAART were all controlled.  Their 
findings indicated no increased incidence of psychiatric conditions in the HIV-
infected children as compared to the control group (psychiatric conditions 
assessed included ADHD, conduct disorder, oppositional defiance disorder, 
generalized anxiety, depression and manic episodes). Two statistical differences 
however were found between the study and control group namely: (1) a higher 
rate of somatisation symptoms reported by the HIV-infected children and (2) use 
of pharmacological interventions for emotional and behavioural problems was 
higher in HIV –infected children.  The limitation remaining in the research include: 
(1) selection criteria for HIV-positive children  were not standardised, (2) wide 
ranges of age groups were  used,  (3) the control group included uninfected 
children born to HIV positive mothers exposed to possibly neurotoxic  
antiretroviral medication and (4) the socioeconomic factors and their influence on 
development of children are always confounding factors.  
 
Research indicating an increase in behavioural and psychiatric conditions 
associated with HIV (Nozyce et al, 2006), did not use a control group to compare 
results. Wolters and Browers (2005) concluded that behavioural problems in HIV-
infected children may be attributed to a combination of central nervous system 
involvement related to HIV infection, the psychological stress associated with 
chronic illness, biological, environmental and genetic factors. 
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 In an attempt to link changes seen on neuro-imaging of the central nervous 
system, CD4+ counts  and behavioural manifestations such as ADHD, conduct 
and anxiety disorders , Nozyce et al (2006) found  no evidence of this.  However, 
only 12% of the children in the cohort had structural changes visible on CT scan.  
In only Mellins et al (2009) a positive association was found between HIV-
positive adolescents and an increased incidence of ADHD as compared to a 
control group. Again, both study and control groups demonstrated higher levels 
of psychiatric dysfunction than the accepted rates of the general population of 
inner city youth of the same age and adolescents with chronic conditions. These 
adolescents represented a group of HIV-infected children born prior to the 
accepted use of HAART and many psychiatric conditions are known to emerge 
during this developmental stage. Mellins et al (2009) have recommended further 
research to identify the possible aetiology of increased prevalence of ADHD in 
HIV-positive adolescents.  
 
No research was found pertaining to the South African HIV-infected paediatric 
population. However in Mellins et al (2003) and Gadow et al (2010), children in 
the study lived in lower socioeconomic conditions, almost half of the mothers had 
not completed high school at time of birth and had a low yearly income. Findings 
of this research may then have some value to our population. In South Africa, 
other factors beside socioeconomic conditions might influence behavioural and 
psychological functioning in children. The legacy of apartheid with its associated 
ramifications on family structure and the associated violence still experienced in 
the communities might play a role. In a study comparing South African and 
similarly matched African American six year olds, all non HIV infected, it was 
found that South African children were less likely to display anxiety, depression 
and hyperactivity but displayed more antisocial and disruptive behaviours 
(Barbarin, 1999). The South African sample was predominantly black children 
living in Soweto.   
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Understanding the causes of behavioural problems in children with HIV is vital as 
the appropriate interventions are needed to ensure an improved quality of life for 
these children (Mellins et al, 2003). Treating behavioural and psychiatric 
conditions may also have the effect of improving adherence to HAART (Mellins et 
al, 2003). Irrespective of the underlying aetiology of the behavioural and 
psychological patterns manifesting in HIV-infected children, management of the 
symptoms is vital to ensure an improved quality of life (Brown et al, 2000).   
 
Psychological and behavioural dysfunction in children with HIV can be treated 
with psycho-stimulants, antidepressants, antipsychotics, anticonvulsants and 
mood stabilisers. Being HIV positive might in-fact increase the child’s chances of 
intervention, especially in resource-poor communities were many uninfected 
children might go untreated due to a lack of medical and or psychological 
facilities. This was evident in Chernoff et al (2009) who found that a higher 
percentage of HIV positive children were receiving an intervention as compared 
to non-infected children despite both groups reporting a high rate of behavioural 
and psychiatric conditions.  
 
Drug interactions have been noted between the traditionally used psychiatric 
medication cited above and HAART (Lourie et al, 2005). Close monitoring of the 
child and consultation with family is essential to avoid the negative drug 
interactions. 
 
2.10   Disclosure 
With the introduction of HAART and its effect on increasing survival rates of 
children infected vertically with HIV, the burden of disclosure has become a 
reality for many parents and care- givers (Wiener et al, 2007). Patterns of 
disclosure include non- disclosure, partial disclosure and full disclosure, with 
partial disclosure being recommended for the younger child (Weiner et al, 2007).  
Disclosure should not be viewed as a once off event, but rather as a process that 
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might continue over a period of time, moving from non-disclosure to complete 
disclosure (Wiener et al, 2007; Lester et al, 2002). 
 
The ideal age of disclosure remains elusive, with no specific age emerging as the 
most appropriate (Wiener et al, 2007; Mellins et al, 2002). It is evident that age is 
not the overriding factor determining rates of disclosure but rather many 
psychosocial factors relating to the child and his family. It is the opinion of the 
American Academy of Pediatrics’ that all children and adolescents, infected with 
HIV, should be informed of their status (1999). However this was based on their 
research on children diagnosed with various forms of cancer and the disclosure 
thereof. It is difficult to compare HIV to paediatric cancer as the medical 
outcomes and social factors are not similar.   
 
Disclosure remains a challenge due to the stigma associated with HIV/AIDS, not 
only for the child but for the family as a whole (Brown et al, 2010; Lesch et al, 
2007;  Lester et al, 2002; Mellins et al, 2002). Disclosure of the child’s positive 
status will ultimately lead to the disclosure of the HIV status of the biological 
mother. Wiener et al (2007) , in a review of research conducted by Flanagan-
Klygis et al (2001), Waugh (2003), Mellins et al (1994) and Wiener et al (1996), 
found that there are a variety of reasons which consistently   prevent parents 
from making full disclosure to their children. These included age and maturity 
level of the child, the fear of the diagnosis being revealed to family and friends, 
stigmatisation and anger from the child and possible depression. For some 
caregivers/ parents, the deteriorating health status of the child might influence 
their decision to disclose to the child and others. As the treatment regimes 
require greater degree of adherence from the child, disclosure might become 
inevitable (Mellins et al 2002). It is often the child’s questioning about his health 
and medication that prompts the need for disclosure (Lester et al, 2002). The 
relationship of trust between caregiver and child may be compromised by 
prolonged non-disclosure (Wiener, 2005). 
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A parent contemplating disclosure to their child will need to consider their child’s 
age, cognitive abilities, emotional development, location of disclosure, their 
familial  cultural norms relating to health and dying, and the content of 
information to be disclosed (Weiner et al, 2007; Wiener, 2005). A concern that 
parents have expressed with regard to disclosure is the fear that death and dying 
might become a preoccupying thought for their children with consequent negative 
effect on their psychosocial adjustment (Lester et al, 2002). This cannot be 
confirmed by the literature as research regarding the psychosocial impact that 
disclosure has on children with HIV remains inconclusive (Wiener et al, 2007). 
Whilst some research has found that less secrecy promotes improved 
psychosocial functioning of the child and the caregivers (Brown et al, 2010), 
there is also a body of literature that states that disclosure has a negative impact 
or no impact on the child (Wiener et al, 2007). Butler et al (2009) found that 
disclosure did not impact negatively on the quality of life of children with vertically 
transmitted HIV.  
 
  Mellins et al (2002) strongly recommend that by early adolescence all children 
should be aware of their HIV positive status. It has been suggested that all 
adolescents and children requiring hospitalisation should be informed of their 
status with the appropriate amount of information for their age, so as to prevent 
inadvertent disclosure by medical staff (Brown et al, 2010).  
 
 There is limited research that has been done regarding age patterns of 
disclosure in South Africa.  Moodley et al (2006), in their study in Cape Town, 
found that the majority of caregivers in their cohort felt that the age of 12 is the 
ideal age to disclose to the child. This contrasted with the opinion of healthcare- 
workers, at a tertiary outpatient HIV clinic, who felt that at the age of 10 was the 
correct age for disclosure (Myer et al, 2006).  
 
 The National Education Policy Act of 1996 prohibits any discrimination against 
attendance/entrance to school, forced testing and/ or disclosure. Disclosure of 
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child’s status can only be done with the caregivers and child’s consent (when age 
appropriate). The policy advocates that a child older than 14 is able to disclose 
his/her status without parental consent. 
 
 There are many moral, ethical and legal ramifications to a parents’ decision on 
disclosure. The issues of adherence, creation of drug resistant strains of HIV and 
sexual transmission are all issues that children with HIV will have to deal with as 
they enter adolescence (Frederick et al, 2000). Whether they are aware of their 
positive status has enormous ramifications in our society. 
 
2.11 Coping Mechanisms and Psychosocial Adjustment 
Children utilise various coping mechanisms to adjust to living with HIV/AIDS 
(Steele et al, 2007). Research on coping mechanisms employed by children 
diagnosed with a chronic illness and their families, has largely been based on 
conditions other than HIV (Martin et al, 2004).  Lazarus and Folkman, in 1984, 
suggested that children may utilise either emotion-focused or problem-focused 
coping mechanisms (Martin et al, 2004). Their definition of the above, as cited by 
Martin et al (2004), states that children using emotion-focused coping 
mechanisms believe that their situation cannot be changed and avoidance 
techniques are utilised. This may be seen as a more passive form of coping 
(Martin et al, 2004).  Children with problem-focused coping skills are able to see 
that a stressful situation is changeable and they generate solutions and learn 
new skills. This is a more active form of coping (Martin et al, 2004). It has been 
found that children using the more passive, emotion-focused strategy report 
more emotional and behavioural problems (Steele et al, 2007). 
 
 One cannot examine the coping skills of a child in isolation. They function as 
part of a family system and hence are influenced by the family and coping 
mechanisms they employ. In their research on coping mechanisms employed by 
the families of children infected with HIV, Martin et al ( 2004) found three main 
patterns of coping mechanisms namely: avoidance (handing over responsibility 
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to health workers ) ; spiritual reinforcement; and seeking out social support from 
outside the family. Due to the associated stigma of HIV/AIDS, use of external 
social support was used less as a coping mechanism by the families. It appears 
that a reciprocal relationship often develops between the child infected with HIV 
and their family. The coping mechanisms employed by the family will affect the 
child’s psychological, developmental and medical functioning (e.g. extent of 
adherence) and in turn the child’s functioning in the above mentioned areas will 
influence the family on choice of coping mechanisms employed (Martin et al, 
2004). 
 
 2.12 Family-Centred Intervention and Psychosocial Adjustment  
The role of the family in the psychosocial adjustment of the HIV-infected child 
has been substantiated from all the above information. The effects of a caring 
and nurturing environment and family can only promote the resilience that 
children are known to possess (Richter et al, 2006). The family can be identified 
as an open system which will have a large influence on the child’s behaviour and 
development. A healthy family system will be able to adapt to and withstand 
negative external and internal stressors such as ill-health (Malcolm, 1998). It 
therefore stands to reason that interventions aimed at improving the psychosocial 
adjustment of the HIV-infected child, and consequently their quality of life, should 
be aimed at the family unit and not the individual child only. Family-based 
interventions aim to strengthen the family system thereby empowering them to 
make and find positive solutions to the stressors experienced by the child, 
thereby improving his health and quality of life (Malcolm, 1998).   
 
2.13 Socioeconomic Factors Affecting HIV-Infected Children in South 
Africa.  
The Poverty Line denotes a monthly/weekly income that separates the poor from 
the non-poor. An income classified to be below the poverty line limits full 
participation in society and attainment of a healthy life style (Van der Berg et al 
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2007).  In South Africa the poverty line has been set at R250/per month or 
R3000/ year (Van der Berg et al 2007).  
 
Throughout the review poverty has been mentioned as a confounding factor in 
the effects of HIV on children. With poverty being so widespread in countries 
where HIV is found in so prevalently, it is often difficult to distinguish between the 
direct effects of HIV on the health of the children (Richter, 2004). Richter (2004) 
questions whether we should in fact be focusing solely on the HIV/AIDS epidemic 
and its affected individuals OR on poverty as a whole with the focus being on 
more widespread interventions directed at social institutions.  
 
 It is the poorest South Africans that are most affected by the HIV/Aids pandemic 
and the consequences for them are often dire. For many, HIV/AIDS has changed 
the family’s economic position from poverty to destitution (Steinberg et al, 2002). 
In a survey by Booysen and Bachman ( 2002), as cited by Andrews et al (2006), 
it was found that families with at least one infected member had a monthly 
income half that of the unaffected households. Consequent to HIV/AIDS, altered 
family dynamics, foster care, living with ill parents, poor access to health care 
and nutritional deprivation have all been seen as socio-economic factors 
affecting children and consequently their QoL (Missmer, 2000). 
 
The death of a parent or caregiver may have a twofold effect on the child, namely 
financial implications and an emotional loss. More time spent with a caregiver 
has been associated with a more positive QoL in children (Xu et al, 2010).  
 Financially, already limited resources may be further compromised with a 
resultant negative impact on the child’s health, and educational opportunities 
(Desmond, 2009; Andrews et al, 2006). Research in South Africa has looked at 
school enrolment of HIV orphans and non-orphans affected by HIV/AIDS. 
Orphans have been shown to have reduced access to education and a higher 
drop-out rate (Andrews et al, 2006).  
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 It has been stated that the loss of a mother has a greater impact on the child’s 
care than the loss of a father (Desmond, 2009). In South Africa, the pattern of 
female headed single parent households and the ramifications of Apartheid on 
family structure are well established (Petersen et al, 2010; Andrews et al, 2006). 
In the poorer communities, children and their fathers often do not reside together 
for a variety of reasons, and female headed households are very common 
(Desmond and Desmond, 2006). According to the General Household Survey of 
2002, a father is present in only 48% of households and a mother in 80% of 
households (Statistics SA, 2002). It is however not accepted that only a nuclear 
family may be considered to be an effectively functioning family system 
(Malcolm, 1998). A strong and supportive family with good access to effective 
services can minimize the effects of HIV/AIDS on children (Desmond, 2009). He 
continues by saying that it is rather the failure to respond to poverty that allows 
HIV/AIDS to continue its negative impact on our children.  
 
 
 
2.14 Quality of Life 
With HIV/AIDS it has become essential to treat the child holistically, looking at 
their adjustment to the illness and its treatment (Harding, 2001).  An additional 
health measure, QoL, has become essential to evaluate intervention outcomes 
for children with HIV/AIDS (Garvie et al, 2009; Lee et al, 2006; Missmer et al, 
2000; Wallender and Varni, 1998).  
 
Quality of Life (QoL) has been defined by the WHO as “the individuals’ 
perception of their position in life in the context of culture and value systems in 
which they live, and in relation to their goals, expectations, standards, and 
concerns.” (WHOQOL, 1997 page 1).The quality of life of the individual is 
influenced by their physical health, psychological state, level of independence, 
personal relationships, beliefs, and environment (WHO, 1997). Quality of life 
defines all aspects of a patients’ well being transcending the medical model 
(Berzon, 1998) 
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The concept of Health Related Quality of Life, as a separate construct, was 
originally created to distinguish between the outcomes in health related research 
and sociological research on healthy populations (Smith et al, 1999). Health  
related Quality of Life (HRQoL) is distinct from QOL in that it examines the 
perceived  effect that illness and subsequent medical intervention  has on the 
varying facets of life, not only physical functioning ( De Civita et al, 2005). It 
reflects the holistic nature of the Classification of Function, Disability and Health 
adopted by the WHO in 2001. 
 
Many authors have attempted to define the concept of HRQoL but with no single 
definition emerging in the literature (De Civita et al, 2005). Despite the numerous 
definitions there are common themes that emerge. HRQoL is a subjective 
appraisal of the impact a disease or condition might have on the functioning of an 
individual. Functioning includes the physical, psychological and emotional well-
being of that individual and his/her ability to participate in their family and 
community in a meaningful way. It further looks at the individuals’ perception of 
their medical status and the effectiveness of the treatment and interventions they 
are receiving (Wallender and Varni, 1998; Shumaker and Naughton, 1997; Eiser, 
1996). Domains of social, physical and cognitive functioning; mobility and self-
care; and emotional wellbeing are critical in any evaluation of HRQoL (Shumaker 
and Naughton, 1997). Evaluating HRQoL requires a two-fold approach for it to be 
meaningful and appropriate. Both the functional impact a medical condition,  or 
treatment thereof, has on the above mentioned domains, and the child’s 
perception of the effects on the domains needs to be considered (Waters et al, 
2009; De Civita et al, 2005). A third construct described in the literature in 
association with QoL and HRQoL, is health status. A clear distinction however 
can be drawn between QoL, HRQoL and health status.  Health status refers 
uniquely to the patient’s perception of their physical functioning only (Garvie et al, 
2009; De Civita et al, 2005). Health status therefore bears no significance to this 
research. 
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 The medical literature appears divided as to the use of the terms QoL and 
HRQoL as separate constructs. Authors have found that the terms are often used 
interchangeably (Clayson et al, 2006; Smith et al, 1999; Wallender and Varni, 
1998) despite recommendations to the contrary (Davis et al, 2006; Shumaker 
and Naughton, 1997).  
 
2.15 Quality of Life of Children with Chronic Diseases 
Living with a childhood chronic disease and the impact thereof on HRQoL has 
become an important research topic in the developed world. Colver (2008) warns 
against assuming that impairment or loss of function would automatically result in 
a child reporting a lower QoL. However extensive research in this field has 
shown, to varying extents, the negative effect of a chronic childhood condition on 
HRQoL (Grootenhuis et al, 2008; Janssens et al, 2008; Maher et al, 2008; Van 
Der Lee et al, 2007; Williams et al,2005; Sawyer et al, 2004; Powers et al, 2003; 
Varni et al, 2002).  It is beyond the scope of this literature review to discuss 
specific chronic childhood conditions and their effect on HRQoL.  
  
 A child living with a chronic disease might not be able to achieve the 
developmental milestones, motor and cognitive, usually achieved by other 
children. This might have a resultant effect of increased dependence on 
parent/caregiver and limitations in peer-interaction and school- based activities. 
These limitations in participation have been shown to affect HRQoL of children 
living with a chronic condition (Grootenhuis et al, 2008). Areas of functioning that 
have been shown to be affected by a chronic condition, with a consequent 
decrease in reported HRQoL, include the physical, emotional, cognitive and 
social aspects of a child’s life (Grootenhuis et al, 2008; Williams et al, 2005). Due 
to the differing medical conditions assessed, different  inclusion and exclusion 
criteria and measurement tools used in the research, it remains difficult to 
analyse which of the above aspects of functioning contribute the most to a lower 
reported HRQoL in children with a chronic condition.  
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In young people living with a chronic condition, HRQoL is dynamic (Taylor et al, 
2008).  HRQoL will continuously shift, not always negatively, depending on the 
child’s developmental stage, personality, their ability to manage their disability or 
limitations in participation, redefinition of goals and ambitions and the disease 
trajectory (Taylor et al, 2008; Eiser and Jenney, 2007). 
 
A search of the literature yielded no published data regarding the HRQoL of 
children with chronic conditions living in South Africa.  
 
2.16 Measurement of Health Related Quality of Life 
HRQoL questionnaires are either generic or condition specific (Waters et al, 
2009; Sawyer et al, 2004; Berzon, 1998, Osoba D, 1998).  Generic tools offer the 
advantage of allowing comparisons between various populations of acute and 
chronic paediatric conditions as well as comparison between ill and healthy 
populations (Waters et al, 2009; Sawyer et al, 2004; Varni et al, 2002; Varni et al, 
2001). The disadvantage of a generic HRQoL questionnaire is the potential 
inability to assess disease-specific factors that may affect HRQoL and treatment 
related changes that may occur (Waters et al, 2009; Sawyer et al, 2004; Eiser 
and Morse, 2001). The domains used to measure HRQoL in a generic 
measurement tool will differ to those used in a disease – specific measurement 
tool (Waters et al, 2009) 
 
 
When choosing a questionnaire several factors must be taken into account 
namely: age, gender, educational level and degree of illness (Garvie et al 2009; 
Berzon, 1998). The level of cognitive development in children will influence their 
ability to use rating scales and understand and complete lengthy questionnaires 
that are often used in adult QoL assessments (Eiser and Morse, 2001). In 
children with HIV/AIDS, disclosure or non- disclosure will influence the choice of 
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using a disease specific measurement tool or a generic measurement tool 
(Garvie et al 2009). Inadvertent disclosure by medical staff needs to be avoided. 
 
The purpose of measuring HRQoL will also dictate the type and length of 
questionnaire chosen.  When screening a large group of individuals to identify 
possible domains of interest for future study and intervention, a brief 
measurement tool is used (Osoba, 1998). The advantages of using a brief 
measurement tool are two- fold: the ability to recruit large numbers of individuals 
into the study and minimal training is required of the interviewer (Eiser and 
Morse, 2001). The length of a questionnaire was not discussed in the literature 
however the recommended time span that a questionnaire should require for 
completion is 10- 20 minutes (Waters et al, 2009). For clinical trials and policy 
decision making, a more detailed measurement tool is required (Osoba, 1998). 
 
The ability for children to self-report on their own quality of life has been debated 
in the literature. Developmental considerations which may hamper self-report 
include limited expressive and receptive language skills; the ability to interpret 
Likert scales; and the inability to understand time frames which involves memory 
and time perception ( Wallender et al, 2001). There is evidence however to show 
that children, as young as five years old, are reliable reporters of their own 
HRQoL (Varni et al, 2007) and child report is essential in measuring HRQoL 
(Varni et al, 2007). It is no longer acceptable to rely purely on parent proxy 
reports concerning their children’s HRQoL (Eiser and Jenney, 2007; Cremeens 
et al, 2006; Sawyer et al, 2004; Varni et al, 1999).  
 
2.17 Measurement Tools 
Two measurement tools were utilized in the research by the author. Both will be 
discussed below.  
 
2.17.1 PedsQL 4.0 Generic Core Scale 
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In reviews of measurement tools, both generic and disease specific, previously 
used for children/adolescents living with HIV/AIDS, no one tool proved ideal 
(Garvie et al, 2009; Clayson et al, 2006).  Measuring HRQoL is unlike measuring 
other health indicators which provide empirical data; it is based on subjective 
opinion which is influenced by an endless array of external factors (Eiser and 
Morse, 2001). The PedsQL 4.0 Generic Core Scales has been found to be a 
valid and acceptable to measure HRQoL in HIV-infected children. It is able to 
distinguish between aspects of HRQoL in infected children and their uninfected 
counterparts (Banerjee et al, 2010).  
 
The PedsQL 4.0 Generic Core Scales (Paediatric Quality of Life Inventory) is a 
brief, standardised generic assessment instrument that systematically assesses 
patients’ and parents’ perceptions of HRQoL in paediatric patients with chronic 
health conditions (Varni et al, 1999). The measurement tool is designed to 
measure the core health dimensions delineated by the WHO namely- physical 
functioning (eight items), emotional functioning (five items), social (five items) 
and school functioning (five items) (Varni et al, 2001).The generic version of the 
PedsQL was designed using paediatric cancer as the model (Varni et al, 1999). 
The PedsQL 4.0 Generic Core Scales are comprised of parallel child self-report 
for ages five-18 and parent proxy- report for ages two -18. (Varni et al, 2006). 
The necessity of using child self-reporting in measuring QoL has been stressed 
in the literature (Rosenbaum, 2008; Eiser and Morse, 2001).  
The PedsQL 4.0 Generic Core Scale, self- report, for five- seven year old 
children was utilised in the research (Appendix I). The questionnaire is based on 
a three- point Likert scale with 0 (Never); 2 (Sometimes) and 4 (A Lot). Scores 
are transformed, using reverse scoring, on a scale of zero- 100. The domains are 
calculated separately as well as a total for all the domains is obtained. In addition 
a total for psychosocial functioning is obtained by combining the social 
functioning, emotional functioning and school functioning domains (Appendix II).  
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For the purpose of this research, the PedsQL Generic Core Scales has proved to 
be the measurement tool of choice due to the following factors: 
 The PedsQL 4.0 Generic Core Scales child self-report, children ages five 
– 18, has been shown to demonstrate internal reliability as determined by 
calculating Cronbach’s co-efficient alpha. For the Total Scale Score (child 
report), alpha = 0.88. Construct validity was determined using the known– 
groups’ method. When using this method, scale scores across groups 
known to differ in the health construct being tested are compared. The 
PedsQL 4.0 Generic Core Scales was found to be valid (Eiser and Morse, 
2001; Janssens et al, 2008; Varni et al, 2007). Test – retest reliability for 
the PedsQL 4.0 Generic Core Scales, using ICC, Pearson correlation 
coefficients, and kappa, all exceeded the 0.60 level (Janssens et al, 2008) 
 The PedsQL 4.0 Generic Core Scales has been found to be of the 
appropriate length for completion by children (Eiser and Morse, 2001). 
 It covers many domains in the International Classification of Functioning, 
Disability and Health (ICF) (Janssens et al, 2008). 
 In a study conducted by Varni et al (2002) the PedsQL 4.0 Generic Core 
Scale, has been shown to display sensitivity when assessing quality of life 
of children attending an orthopaedic out-patient clinic for treatment of 
fractures. 
 
2.17.2 International Classification of Functioning, Disability and Health 
The International Classification of Functioning, Disability and Health (ICF) was 
introduced in 2001 (Simeonsson et al, 2006). The child and youth version (ICF-
CY) was later introduced to improve coverage from birth to age 17. The ICF-CY 
offers a framework and common terminology to identify and research problems 
associated with body structures and functioning, activity limitations and 
participation restrictions. Influencing external factors, both positive and negative 
are also included. In terms of the PedsQL 4.0 Generic Core Scale, it has been 
found to cover the domains of activity limitation and participation in the ICF-CY 
(Janssens et al, 2008). The effects of a chronic disease on the HRQoL of a child 
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would be evident in the activity limitations and participation experienced by the 
child. 
 
2.17.3 Household Economic and Social Status Inventory 
It has emerged that measuring socioeconomic status should not rely purely on 
self-reported income (Barbarin and Khoma, 1997). The use of self-reported 
income as a poverty measure proves problematic due to inaccurate reporting 
(Barbarin and Khoma, 1997).  For the purposes of this research the Household 
Economic and Social Status Inventory (HESSI) was utilized to assess the 
socioeconomic status of the study and control group (APPENDIX III). Following 
their research between 1990 and 1996 on a cohort from Soweto, South Africa, 
Barbarin and Khoma (1997), were able to develop an instrument to measure 
material and social welfare that is sensitive to and reflects the variations within 
urban poor people. The instrument comprises various indicators that “reflect the 
economic and social circumstances characterizing the child-rearing environment 
among the poor” (Barbarin and Khoma, 1997).  
 
2.18 Health Related Quality of life of Children infected with HIV 
The pre-ceding chapters dealing with HIV have drawn a clear picture of the many 
direct and indirect ways that HIV might impact on the quality of life of an 
individual. There has been a rapid increase in interest and research into 
measurement tools for HRQoL in adult patients with HIV/AIDS (Garvie, 2009; 
Clayson et al, 2006; Berzon and Lenderking, 1998; Shumaker and Naughton, 
1997; Hays and Shapiro, 1992).However research into measurement tools used 
to measure HRQoL in children with HIV/AIDS has not been increasing at the 
same rate (Garvie et al, 2009). Since the commercial availability of HAART, no 
new measure of HRQoL for youth with HIV/AIDS has been established and 
validated (Garvie, 2009). 
 
Researchers have used HRQoL as one of their outcomes to monitor and assess 
efficacy of HAART regimes (Lee et al, 2006; Storm et al, 2005) but few have 
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used HRQoL as the focal aim of their research (Banerjee et al, 2010; Bomba et 
al, 2010; Xu et al 2010; Oberdorfer et al, 2008). 
 
 There is research using children infected with HIV (Banerjee et al, 2010; Bomba 
et al, 2010; Xu et al 2010; Oberdorfer et al, 2008)   and research using children 
affected by HIV ( have at least one infected parent) but not infected themselves   
(Xu et al, 2010). Thirdly there is a body of literature based on orphans and 
vulnerable children affected by HIV but without specific indication of the HIV 
status of the child (King et al, 2009; Richter, 2004). The term “orphans and 
vulnerable children” was first conceptualised by Foster and Williams in 2000 
(Earls et al, 2008). Most of the research looking at the psychosocial effects of 
HIV/AIDS on children utilises these concepts. Skinner (2006) uses the definition 
of an orphan as a child younger than 18, who has lost either one parent (mother 
or father) or both parents (double orphan). UNICEF refers to maternal orphans, 
paternal orphans and double orphans (UNICEF, 2004). The definition of 
“vulnerability” has proven to be more culturally sensitive and diverse between 
countries, with no consistent definition emerging. In South Africa children are 
who are disabled, seen to be neglected, destitute or abandoned, living with 
terminally ill parents, born to single mothers, living with an unemployed 
caretakers,  or who are abused or ill-treated by care-takers  have all been 
identified as being vulnerable ( Skinner, 2006). 
  
An analysis of research projects looking at HRQoL as the central outcome 
measure has shown that it is not only the positive HIV status of a child that will 
predict a lower quality of life but also living in a household affected by HIV. Xu et 
al (2010), using the PedsQL 4.0 Generic Core Scales, aimed to identify factors 
affecting the HRQoL of children affected by HIV. Of note is that only uninfected 
children living in a household affected by HIV were eligible for the study group. 
An affected household was considered to be one in which there was at least one 
HIV-infected parent or one or both were deceased due to HIV. A suitable control 
group of unaffected   neighboring families was chosen. Children in affected 
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households reported significantly lower quality of life scores. HRQoL, as reported 
by the child, was found to be negatively affected by poor levels of self-esteem, 
caregivers’ decreased QoL, and disclosure of parent’s positive HIV status. 
Contrary to most research, a child experienced a better QoL when the caregiver 
was a grandparent.  
 
In research carried out in Thailand, Oberdorfer et al (2008) found a direct 
relationship between reported QOL and CD4 percentage. Children with a CD4 
count higher than 25% were reported to have a significantly higher QOL as 
compared to children with a CD4 count less than 25%. This research was based 
on parent- report and no control group was used. Without the use of a control 
group, values cannot be compared for uninfected children and no normal data 
and values, specific to Thailand are obtained. Very little data was available on 
exclusion and inclusion criteria of the children used in this research. 
Measurement tool used in the research was the General Health Assessment for 
Children developed by the Pediatric AIDS Clinical Trial Group (ACTG). 
 
Using the PedsQL 4.0 Generic core Scales , Bomba et al (2010) and Banerjee et 
al (2010), were able to demonstrate a significant difference in the HRQoL of HIV-
infected  children as compared to a control group. Bomba et al (2010) used a 
sample of healthy randomly selected matched children whereas Banerjee et al 
(2010) used uninfected siblings and randomly selected healthy institutionalized 
children. Domains of physical functioning, emotional functioning and school 
functioning were affected in HIV-infected children in both studies. Limitations in 
Bomba et al (2010) included the limited number of children (27 in each group), 
and a large age-range (five-18 years of age) reflecting children in various stages 
of development which might affect perceptions of HRQoL and limited 
demographic data on subjects available. 
 
It is difficult to compare data and results from all four research projects as 
different research tools, samples and methods were used. However certain 
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conclusions can be drawn concerning the HRQoL in HIV-infected children.  HIV 
is a fluctuating chronic disease and therefore HRQoL would need to be assessed 
on a continuous basis thereby ensuring adequate and appropriate interventions. 
Despite the introduction and widespread use of HAART, HRQoL in HIV-infected 
children is still affected and children may require intervention. 
 
 
2.19 Conclusion 
HIV/AIDS remains a chronic medical condition without a cure. It is a disease that 
affects all spheres of a child’s life and their potential to participate in their family, 
social group and community.  Continuous assessment of their HRQoL can 
perhaps help institute interventions that might help mitigate the negative effects 
of HIV/AIDS. The research describing and analyzing the HRQoL of the young 
HIV-infected child is limited, and requires more investigation. The PedsQL 4.0 
Generic Core Scale has been found to be an appropriate measurement tool to 
analyze HRQoL in children infected with HIV. 
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Chapter 3: Methodology 
 
In this chapter the methodology used in this research report will be presented. 
This is a cross- sectional study. 
 
3.1 Location of study 
This study was carried out at Charlotte Maxeke Johannesburg Academic 
Hospital and Chris Hani Baragwanath Hospital. Both hospitals are government 
run institutions and are situated in Johannesburg, South Africa. The study group 
was obtained from the Harriet Shezi Children’s HIV clinic at Chris Hani 
Baragwanath Hospital and the paediatric HIV out-patient clinic at Charlotte 
Maxeke Academic Hospital. The comparison group of children was obtained from 
the paediatric orthopaedic out-patient clinics at each of the above hospitals and 
the paediatric out-patient dermatology clinic at the Charlotte Maxeke Academic 
Hospital. 
 
3.2 Ethical Clearance 
Prior to commencement of data collection, ethical clearance was obtained from 
the University of the Witwatersrand Human Research Ethics Committee 
(Clearance number: R14/49 Goldberg, protocol number M081131) (Appendix IV). 
Further permission, in writing, was obtained from the respective hospitals to 
conduct the research.  At each of the out-patient clinics, the research was 
discussed with the managing doctor and approved. Written informed consent 
was obtained from all caregivers and children participating in the research 
(Appendix V). To maintain privacy, no names were used in the research, with 
each child been identified by a number only. 
 
3.3 The Study Population 
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The data from 89 children, and their respective care-givers, who fulfilled the 
inclusion and exclusion criteria, was analyzed. The children in both groups 
resided in Soweto, Alexandra and Hillbrow, thus all coming from similar socio-
economic backgrounds.  
 
3.4 Sample Selection 
 
3.4.1 Study group 
The data was collected from 45 consecutive children, aged six or seven, and 
their caregivers attending the respective HIV out-patient clinics. All 45 children 
had a confirmed diagnosis of HIV and were receiving treatment at the clinics on a 
regular basis.  
 
Inclusion criteria 
 Children with a CD4 count ≥ 25% were included in the study group. 
 Children on HAART for a minimum duration of three months and longer. 
No specific regime of HAART was required.  
 
Exclusion criteria 
 Children in the study group who had any other chronic condition e.g. 
juvenile rheumatoid arthritis, haemophilia, active tuberculosis. 
 Children presenting with clinical signs of physical and mental impairments 
that would impact on their quality of life. 
 Children with severe physical and sensory deficits that render them 
unable to complete the PedsQL 4.0 Core Scale. 
 Children who had been on antiretroviral therapy for less than three 
months. 
 Children in the study group naive to HAART. 
 Children living in an institution or foster care. 
 Any children brought to the clinic by a family member unaware of the 
child’s HIV status 
43 | P a g e  
 
  
 
3.4.2 Comparison group 
The comparison group was a sample of convenience. The data was collected 
from 44 children, aged six or seven, and their caregivers attending the respective 
clinics. 
Inclusion criteria 
 Children aged six or seven 
 Attending only the orthopaedic out-patient clinic or dermatology out-patient 
clinic respectively. 
Exclusion Criteria 
 Any children in the comparison group who had previously been  
diagnosed with HIV/AIDS on admission to hospital or after discharge 
 Children with any pre-existing diagnosed chronic condition that requires 
regular monthly clinic visits, and numerous days away from school every 
month. 
 Children with extensive atopic dermatitis which may impact on their 
physical and emotional functioning. 
 Children with multiple orthopaedic  injuries that may impact on level of 
physical functioning or quality of life 
 Children requiring any assistive devices for mobility or school function. 
 Children in the comparison group requiring further orthopaedic 
management or interventions 
 Children who reside in institutional care or foster-care. 
 Children with severe physical and sensory deficits that rendered them 
unable to complete the PedsQL 4.0 Core Scale. 
 Children from different socio-economic background. 
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3.5 Assessment tools 
 The PedsQL 4.0 Generic Core Scales Child report for children aged five-seven 
was used. The measurement tool was used with permission from the author and 
the Mapi Research Trust .This tool was devised to measure the HRQoL in 
children aged 2-18 years and covers the domains of social, emotional, physical 
and school functioning. The length of time to administer the test is approximately 
15 minutes.  
 
 The Household Economic and Social Status Inventory (HESSI) were used to 
collect socio-economic data. This is a tool that was developed in Soweto and has 
been used extensively in research in South Africa (Barbarin 1997; Potterton, 
2007). 
 
Additional information gathered from the patients’ files included: CD4+ 
percentages, viral load status at time of research and the duration of HAART. For 
both groups of children, height and weight were measured. 
 
3.6 Procedure 
 
3.6.1 Translation of PedQL4.0 Generic Core Scale 
The PedsQL 4.0 Generic Core Scales was translated into Zulu using the 
translation agreement and procedure specified by the author and Mapi Research 
Trust. This procedure involved two independent translations of thePedsQL 4.0 
Generic Core Scale edited into a final document. Back translations were required 
and reports of the procedure had to be submitted to the Mapi Research Trust. As 
per the agreement, both the child self-report and parent proxy report, for children 
aged five to seven, were translated. In this research however only the child self-
report questionnaire was utilised. To ascertain the cognitive reliability of the 
translated PedsQL 4.0 Generic Core Scale, for children aged five-seven, the 
questionnaire was administered to five children and caregivers. The results were 
analysed and a report written to the author of the questionnaire and Mapi 
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Research Trust. Permission was then granted to use the questionnaire. Certain 
terminology in the document required altering, with agreement by the author, to 
enable a more accurate Zulu translation. ( APPENDIX VI) 
 
 
 
3.6.2 Study Group 
Data was collected from 45 children aged six or seven years attending the HIV 
out-patient clinics at Charlotte Maxeke Academic Hospital and Harriet Shezi 
Clinic at Chris Hani Baragwanath Hospital. Prior to commencement of study a 
research assistant was trained to administer the measurement tool. The research 
assistant was able to communicate in various South African languages and 
English. Questionnaires were administered by the research assistant, with the 
principle researcher present at all interviews. As required by the translation 
agreement set out by Mapi Research Trust and the Author of the PedQL 4.0 
Generic Core Scales, the questionnaire was piloted on five suitable children and 
caregivers. A report of the results was submitted for their approval. The 
questionnaires have been included  
 
For the study group, suitable children were chosen by gathering the appropriate 
information from the file regarding the age, CD4+ percentage, viral load and 
duration of HAART. Caregivers were approached and informed about the nature 
of the research and the lack of disclosure involved. Informed consent was 
obtained from caregiver and assent was obtained from the child. All interviews 
were carried out in private with only the caregiver, child, research assistant and 
principle researcher present. The PedQL 4.0 Generic Core Scale child-report 
was administered to the child in a language understood by the caregiver and 
child. The questionnaire was administered as per requirements stated in the user 
agreement. As per exclusion criteria, if the child was unable to complete the 
questionnaire due to a lack of understanding or  cognitive impairment, the child 
was excluded. 
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Additional information gathered included the weight and height of the child. The 
weight of each child was measured using the same scale (measured in 
kilograms) and the height was measured using the same measuring tape and 
method (measured in centimeters). The height was obtained by the child 
standing, without shoes, against a wall and measured from top of head to the 
floor. 
 
Socioeconomic information gathered from the caregiver encompassed marital 
status, highest educational level achieved, employment, nature of housing, 
access to social grants, and the ownership of various household possessions.  
 
3.6.3 Comparison group 
The above procedure was followed in obtaining children from the Orthopaedic 
out-patient clinics at Charlotte Maxeke Academic Hospital and Chris Hani 
Baragwanath Hospitals respectively. In addition children were also selected from 
the out-patient dermatology clinic at Charlotte Maxeke Academic Hospitals. 
Other clinics were not utilized so as to avoid selecting children with chronic 
diseases/conditions that could severely impact on their HRQoL. A total of 44 
children were recruited into the comparison group. So as to further exclude 
children with chronic medical conditions, outpatient files and appointment records 
were checked, with caregiver consent, for history of hospital visits. Children in the 
comparison group were not required to undergo HIV testing nor were the 
caregivers questioned regarding the HIV status of the child. However if 
appointments for HIV outpatient clinics were noted in the out-patient records, the 
child was not selected.  
 
Questionnaire administration, data collection and analysis followed the same 
procedure as for the study group. 
 
 
47 | P a g e  
 
3.7 Sample Size 
A sample size of 40 children in each group will have 90% power to detect a 
difference in mean scores in the PedsQL 4.0 Generic Core Scale, between 
children with HIV and comparison group, of 10.00, assuming that the common 
standard deviation is 15.00 using a two-group t-test with a 0.05 one-sided 
significance level (Dixon and Massey, 1983; O’Brien and Muller, 1983). A final 
sample of 45 children with HIV was selected and 44 children in the comparison 
group. 
 
3.8 Statistical Analysis 
Various statistical tests were utilized in the analysis of the data. Fischer’s exact 
test was used to analyze the demographic data. Fishers exact test was 
appropriate to use in the 2×2 tables with very small expected frequencies 
(Machin et al, 2007). Each domain total (Physical Functioning, Emotional 
Functioning, Social Functioning, School Functioning) was analyzed separately 
using Welsch-t test.The Welsch-t test is appropriate to use for two samples with 
possible unequal variances. Further analysis of all the domains as a single vector 
was done using Hotelling T²-test.This is used to compare means from two 
populations. In order to establish any covariants to the domains of the PedQL4.0 
Generic Core scales, Anova test was done.  
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Chapter 4: RESULTS 
 
In chapter 4, the results of the study will be presented. 
 
4.1 Demographics 
 
4.1.1 Gender Distribution 
The gender distribution of the subjects participating in this study is shown in the 
table below 
 
Table 4.1 Gender distribution 
 HIV 
Positive 
Group 
(n=45) 
Comparison 
(n=44) 
 
Female 
 
21 (46.67%) 
 
19 (43.18%) 
 
Male 
 
24 (53.33%) 
 
25 (56.82%) 
 
(p = 0.83) 
 
Eighty- nine children, 45 with a confirmed HIV diagnosis and 44 children in a 
comparison group were systematically questioned during the study period. Both 
groups were well matched for gender with no significant difference noted 
between the two groups (p= 0.83). The researcher did not set out intentionally to 
match gender, the above gender distribution was achieved randomly and 
unintentionally. 
 
4.1.2 Age Distribution 
The age distribution of the subjects participating in this study is shown in the 
table below. 
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Table 4.2 Age Distribution of the Sample 
 Positive   Comparison p -value 
Mean Age 
(sd) 
(95% cit.) 
6.93 
(± 0.5) 
(6.75 ;7.10) 
6.74 
(± 0.5) 
(6.58 ;  6.90) 
0.12 
 
 All the children in the study were aged six or seven. Using a Two-Sample t-test 
with equal variances no statistical difference was seen in the average age in 
each group. The mean age in the study group was 6.93 years and 6.74 years in 
the comparison group (p=0.12).  
 
4.1.3 Composition of Comparison group  
The comparison group was obtained from the orthopaedic and dermatology out- 
patient clinics.  Children chosen to participate in the comparison group were 
diagnosed with either atopic dermatitis or a fractured lower limb or an upper limb. 
 
 
Fig: 4.1 Composition of the comparison group by diagnosis and number 
  
4.2 Socioeconomic Environment 
Socioeconomic data was collected from the primary caregivers in both groups 
regarding the household environment in which the children reside. 
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4.2.1 Caregiver Relationship and Distribution 
 
Fig 4.2: Caregiver distribution of sample by number 
 
A significant difference was noted between the two groups with respect to 
primary caregiver of the child. In the study group only 28 (62.22%) as opposed to 
39 (88.64%) children in the comparison group had their mother as the primary 
caregiver (p=0.01). The children in the study group were more likely to have a 
grandmother (17.78%) or an aunt (20%) as the primary caregiver than in the 
comparison group 2(4.55%) and 2(4.55%) respectively. There were no significant 
differences noted in the marital status of the primary caregiver (p = 0.51). The 
adult escorting the child on the day of assessment was not automatically deemed 
to be the  primary caregiver. The primary caregiver was ascertained as the 
person primarily looking after the child, responsible for the welfare of the  child 
and the person responsible for medical decision making  for the child. 
 
4.2.2 Caregiver Education Level 
 
The table below indicates the highest education level obtained by the caregivers 
of the subjects participating in the study.  
 
0
5
10
15
20
25
30
35
40
45
BIRTH MOTHER GRANDMOTHER AUNT FATHER
HIV POSITIVE
COMPARISON
51 | P a g e  
 
Table 4.3 Educational Level of Caregiver  
Education 
level 
HIV Group 
(n=43) 
Comparison 
group 
(n=42) 
≤grade 11 26 
60.47% 
14 
33.33% 
Grade 12 16 
(37.21%) 
16 
(38.10%) 
Tertiary 
educ. 
1 
(2.33%) 
12 
(28.57%) 
(p=0.001) 
 
 A significant difference between the highest levels of education of caregiver was 
found between the two groups. It is evident that in the study group the majority of 
caregivers are distributed between the lower two categories. In contrast, the 
caregivers in the comparison group are distributed in the upper two categories 
with as many as 28.57% reaching level of tertiary education. For four of the 
participants (two in each group), information regarding the highest educational 
level of the caregiver was unavailable. 
 
4.2.3 Employment status of caregiver and Care Dependency Grants  
The results show that even though there is no significant difference in the 
employment rate of the care-givers in the study group (p =0.28), there is however 
a significant difference between the number of children who receive social 
support grants - with 75% of HIV positive children receiving grants as opposed to 
only 53.49% of the comparison group receiving grants (p = 0.05). The grants 
received refer to Care Dependency grants and not Disability grants. 
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Table 4.4 Employment status of primary caregiver and care dependency 
grant   
 HIV positive 
(n=44) 
Comparison 
 (n=43) 
p value 
 
Caregiver 
employed 
22 (50%) 27(62.79%) 0.28 
Care Dep. 
Grant 
received 
33 (75%) 23 (53.49%) 0.04 
 
 
4.2.4 Housing 
From the HESSI questionnaire, the researcher was able to establish that there 
were four types of dwellings that were the most common and, using Fisher’s 
exact test, showed no significant difference in the two groups. The most common 
form of housing in both groups was the stand alone brick house (56%). The 
shacks seen in the informal settlements accounted for 12% and apartments 15% 
for the total. There were 3 children reported to be living in a single garage 
structure. 
 
Fig 4.3 Type of Housing by number 
 
 
Other items measured in the HESSI indicating economic standard showed no 
significant differences between the two groups. These items include the 
possession a television, DVD machine, cell phone, washing machine, microwave 
and a motorcar. 
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4.3 Anthropometric Analysis (Height, Weight and BMI) 
The table below illustrates the differences in height and weight of the subjects 
participating in the study. The weight is measured in kilograms and the height in 
centimetres.  
 
Table 4.5 Growth Parameters of children  
Growth  
Parameters 
HIV Positive 
n= 43 
Comparison 
 n=44 
Welch T-Test 
p-Value 
Height  
Mean (sd) 
(95% ci) 
113.3 (6.3) 
(111.4 ; 
115.2) 
 
119.9 (5.7) 
(118.1 ; 121.6) 
 
p < 0 .01 
Weight 
Mean (sd) 
(95%ci) 
20.3 (3.0) 
(19.4 ; 21.2) 
 
22.8 (4.7) 
(21.4 ; 24.3) 
 
p< 0.01 
BMI 
Mean (sd) 
(95%ci) 
15.6 (1.6) 
(15.1 ; 16.1) 
 
15.8 (2.5) 
(15.0 ; 16.5) 
 
p=0.75 
 
The above results indicate that despite significant difference in height (p<0.01) 
and weight (p<0.01) between the children in the study and comparison groups, 
the BMI of the children are not significantly different (p=0.75).  This indicates that 
their weight and height are in proportion.The WHO-Multicentre Growth Reference 
Study Standards were not utilised as the data for height and weight was not 
analysed by sex but rather as a mean for each group. Data regarding height and 
weight of two children in the study group was not measured. 
 
4.4   Analysis of the PedsQL 4.0 Generic Core Scale Results  
The PedsQL 4.0 Generic Core Scale child-report consists of 23 equally weighted 
questions separated into four domains (physical functioning, social functioning, 
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emotional functioning and school functioning). A better HRQoL is associated with 
a higher score. If more than 50% of the questions in a domain are not answered, 
that domain cannot be calculated. If more than 50% of the entire questionnaire is 
unanswered, the scale cannot be calculated. All the participants completed the 
questionnaire. 
 
Table 4.6 PedsQL Results 
PedsQL 
Domain 
HIV (n=45) 
Mean (sd) 
(95% CI) 
Comparison 
(n=44) 
Mean (sd) 
(95% CI) 
HotellingT² 
test 
p-value 
Welch t-
test 
p- value 
PF 
 
 
EF 
 
 
SF 
 
 
SCF 
71.4 (23.6) 
(64.3 ;78.5) 
 
74.3 (21.3) 
(67.9 ; 80.7) 
 
77.3 (22.2) 
(70.7 ; 84.0) 
 
71.6 (20.2) 
(65.6 ; 77.6) 
86.8 (11.6) 
(83.3 ; 90.4) 
 
82.5 (15.6) 
(77.9 ; 87.2) 
 
88.7 (13.5) 
(84.5 ; 92.8) 
 
79.5 (14.9) 
(75.0 ; 84.0) 
 
 
 
 
p<0.01 
p<0.01  
 
 
 
p=0.04 
 
 
p<0.01 
 
 
p=0.04 
EF+SF+SCF 
(Psychosoc) 
 
73.9 (17.7) 
(68.6 ; 79.2) 
83.6 (10.6) 
(80.4 ; 86.8) 
  
p<0.01 
Total Score 
 
73.8 (14.9) 
(69.3 ; 78.3) 
84.7 (8.9) 
(82.0 ; 87.4) 
  
p<0.01 
 
PF= physical Functioning; EF=Emotional Functioning; SF= Social Functioning; SCF=School Functioning; Psychosocial = 
emotional+ social+ school functioning 
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With respect to the PedQL domain vector (PF, EF, SF, SCF) the HIV and 
comparison groups differed significantly (p=0.0018), in particular, significant 
differences were detected for each of the domains using Welch t-test (p<0.01; 
p=0.04; p<=0.01; p=0.04). Controls had higher scores in all domains and in total 
score. From the data, it appears that the physical functioning of the children 
infected with HIV displays the greatest disparity as compared to the children in 
the comparison group. When controlling for the possible co-variants Care-giver 
relationship, care-giver education level and social grant, only for Physical 
Functioning caregiver relationship was a significant co-variant and after adjusting 
for this, (p<0.01) 
 
4.5 Analysis of HRQoL, CD4+, Duration of HAART Treatment and Viral load  
 
Using a Regression Analysis and plotting of data, no relationship could be 
established between the total scores obtained on the PedsQL 4.0 Generic Core 
Scale, CD4+ percentages and duration of HAART. The average percentage of 
CD4+ was 33.21%  In addition, due to the nature of reporting of viral load in 
patient files, the author was unable to analyse the effects of viral load on HRQoL. 
The nature of viral load reporting depended on the clinic where the child attended 
It was reported as either < 25 copies/mL or as having the “lowest detectable 
level” (LDL) as opposed to an actual viral load measure. The average duration of 
HAART treatment was 2.6 years. 
 
4.6 Summary of Findings 
 
In this research, the HRQoL of 89 children was evaluated. The children were 
divided into a study group (45 children known to be HIV positive) and a 
comparison group (44 children). Both groups were well matched for gender and 
age. Significant differences found between the two groups were with respect to 
the primary caregiver, highest educational level achieved by primary caregiver 
and  care dependency grant status. Analysis of the height and weight of all the 
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children revealed a difference between the two groups, with the HIV-infected 
children being both significantly shorter and lighter than the comparison group.  
 
The HRQoL, as measured by the PedQL4.0 Generic Core Scale child self-report 
(ages five-seven), indicated a significant difference between the two groups of 
children. The HIV-infected children were found to have a lower overall HRQoL 
with all four domains (Physical Functioning; Emotional Functioning; Social 
Functioning and School Functioning) showing significant differences. The domain 
of Physical Functioning showed the greatest difference between the two groups. 
 
No relationship could be found between CD4+, duration of HAART treatment, 
viral loads and the reported HRQoL of the HIV-infected children. These results 
will be discussed in chapter five. 
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Chapter 5: DISCUSSION 
 
In chapter five the results obtained from the study will be discussed, and 
compared to data obtained from other relevant research pertaining to HRQoL 
and HIV. Furthermore the limitations of the study and recommendations for future 
studies will be discussed.  
 
5.1 Demographics 
In this study the HRQoL of 89 children (45 known HIV- positive children and 44 
control children) was evaluated, using the PedsQL 4.0 Generic Core Scale. Both 
groups were well matched for age (all children were either aged six or seven with 
p= 0.12), and gender (p=0.83). Previous studies using this assessment tool with 
children who are HIV positive have used children of a wider age range (Banerjee 
et al, 2010; Bomba et al, 2010) and smaller number of children (Bomba et al, 
2010). By limiting the age range in this research, the influence of developmental 
and life stages (e.g. adolescence) on perceptions of HRQOL would be reduced. 
Adolescent children infected with HIV, face many challenges that would influence 
their perceptions of HRQoL (Mellins et al, 2004).  
 
The cognitive and psychosocial effects of poor socio-economic status on child 
development are well documented (Chandan and Richter, 2009; Earls et al, 
2008). Therefore it is imperative that in assessing quality of life, the effect of 
socio-economic status cannot be ignored. In order to limit the variations in 
socioeconomic status within the study and comparison groups, all the children 
assessed were chosen from two public hospitals namely Chris Hani 
Baragwanath and Charlotte Maxeke Academic Hospital, servicing children from 
areas traditionally associated with poor socio-economic backgrounds. All of the 
children, with the exception of one child, resided in the greater Soweto area, 
Alexandra and Hillbrow. None of the children had access to private medical care 
and were completely reliant on state care. There were no significant differences 
found in the rate of employment of caregiver, type of housing, sanitary facilities 
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and household items (television, DVD player, fridge, microwave, washing 
machine and motor vehicle).  
 
There was however a significant difference noted between the two groups with 
respect to whether or not the children were receiving a  care dependency  grant 
(p=0.04). The caregivers of HIV infected children were more likely to be receiving 
financial support from the government in the form of a care grant. This grant is 
not specifically aimed at HIV positive children but rather for all children (healthy 
or ill) being cared for in a poor economic environment; however caring for a child 
who is HIV positive is more costly to the caregiver (Petersen et al, 2010). In this 
research the primary caregiver was not necessarily the person accompanying the 
child to the clinic but rather the person primarily responsible for the child. The fact 
that more caregivers of HIV positive children require a care grant points to the 
vulnerability of the families and children. The socioeconomic impact of HIV on 
families has been discussed in the literature review. Further indicating the 
vulnerability of the children with HIV in the study group was the significant 
difference in highest education level of the caregiver in the study group (p<0.01).  
The level of education of the primary caregiver has been associated with 
socioeconomic status (Varni et al, 2001).  
 
The nature of the caregiver relationship, between the two groups, was found to 
be significantly different (p=0.01). Children with HIV were less likely to be looked 
after by their biological mother as compared to the comparison group. This is 
easily explained by the nature of the disease and its progression to death if not 
treated. In this report it was found that only 62.22% of the children in the study 
group were primarily cared for by their biological mother. This was similar to 
Bomba et al (2010) where 63% of the HIV-infected children lived with their 
biological mother. The percentage of children in this current research, with their 
biological mother as the primary caregiver, differs significantly from Potterton et 
al (2009) who found that in their cohort, obtained from the same clinic at Chris 
Hani Baragwanath Hospital, the biological mother was the primary caregiver in 
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81% of the children. The significance arises from the age difference in the two 
groups. In Potterton et al (2009), the average age was 18 months, with all 
children younger than two and a half years. This shows that as the age of the 
HIV-infected children increases, the likelihood of them having become maternal- 
orphans increases. Richter (2004) estimates that between 20% and 30% of 
children affected by HIV, by the ages ten to 14 would have lost their biological 
mother if she was HIV positive. The consequences of this on the child are 
numerous with them being affected medically, financially, socially and 
psychologically (Desmond, 2009; Andrews, 2006).   
 
 5.2 Comparison group 
The comparison group was chosen as a sample of convenience from the 
paediatric out-patient orthopaedic clinics (Chris Hani Baragwanath Hospital and 
Charlotte Maxeke Academic Hospital) and the dermatology out-patient clinic 
(Charlotte Maxeke Clinic). The choice of using these children as opposed to a 
sample obtained from the community or a school setting was to try and eliminate 
the possibility of the children in the comparison group being HIV positive. For 
ethical reasons the children in the comparison group did not require HIV testing. 
To limit the possibility of HIV infection, hospital out-patient records in the 
caregivers’ possession were checked, with consent, to establish any previous 
admissions and clinic visits that would point to the possibility of HIV infection. 
Strict admission criteria were followed to avoid the admission of children with 
other chronic diseases that would have influenced their reported HRQoL.  
 
5.3 PedsQL 4.0 Generic Core Scales 
The PedsQL 4.0 Generic Core Scales has been found to be a valid and reliable 
HRQoL measurement tool in children with chronic diseases, school-going 
children (Varni et al, 2006; Varni et al, 2001; Eiser and Morse, 2000; Varni et al, 
1999) and children infected with HIV (Banerjee, 2010).There is no consensus in 
the literature with regard to the most appropriate measurement tool to be used in 
HIV research (Clayson et al, 2006). The very nature of the disease with its 
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changing impact on the individual requires the varied use of measurement tools 
most appropriate for that stage.  The PedsQL 4.0 Generic Core Scales proved 
ideal for the purposes of this research due to its validity, reliability, length and 
ease of administration, as well as the fact that the terms HIV and/or AIDS are not 
used, thereby avoiding inadvertent disclosure to the child. There was no prior 
knowledge on whether the child was aware of his/her positive HIV status. This 
often dictates the use of a generic HRQoL measurement tool and not a disease 
specific tool (Garvie et al, 2009). The objective of this research was not to 
analyse treatment or clinical outcomes thereby allowing for the use of a generic 
measurement tool as opposed to a disease specific measurement tool (Eiser and 
Morse, 2000). 
 
The results from this research show that the children in the study group (with 
known HIV infection) scored significantly lower in all four domains of the 
PedsQL4.0 Generic Core Scale (Physical Functioning, Social Functioning, 
Emotional Functioning, School Functioning), with an overall total score 
significantly lower than the comparison group indicating a lower quality of life as 
compared to the comparison group (p<0.01). It has previously been shown, using 
the PedsQL 4.0 Generic Core Scale that children with chronic diseases score 
lower in all four domains with a subsequent lower reported quality of life (Varni et 
al, 2001). The mean scores of the HIV infected children in this research study 
group were lower than those reported by children with other chronic diseases as 
reported by Varni et al (2001). The specific chronic conditions were not indicated 
in Varni et al (2001). No research was found pertaining to the reported HRQoL of 
children with chronic medical conditions, other than HIV, in Africa.  
  
In this research, the domain of physical functioning revealed the most significant 
difference between the study and comparison groups (p<0.01). This correlates 
with the results from Bomba et al (2010) conducted in Italy.  The decrease in 
physical functioning could possibly be attributed to the known fact of growth 
stunting and weakness in children with HIV infection (Isanka, 2009; Potterton et 
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al, 2009; Storm, 2005; European Collaborative Study, 2003; Missmer et al, 
2000). This marked differences in height and weight between the two groups was 
evident in this research (p<0.01 and p=0.04 respectively).When controlling for 
possible covariants for physical functioning, only care giver relationship was 
found to be a significant covariant (p<0.01). Caregiver education level and grant 
status were not found to be significant covariants on the physical functioning. The 
reason for the influence of caregiver relationship on the physical functioning of 
the child remains unclear. The negative effect of HIV infection on the physical 
functioning of children has been demonstrated in other studies, using various 
other assessment tools (Lee et al, 2008; Oberdorfer et al, 2008; Missmer et al, 
2000).   
HIV-infected children scored significantly lower in the domains of Social, 
Emotional and School Functioning (p<0.01; p=0.04; p=0.04 respectively). With 
respect to social functioning, this result differs to Banerjee et al (2010) where 
HIV-infected children scored higher scores in this domain as opposed to 
uninfected children. Bomba et al (2010) found no difference in social functioning 
between their two groups. Banerjee et al (2010) suggest that the better social 
functioning found in their HIV-infected children, could relate to the exposure to 
increased emotional and social interventions that are offered at the HIV clinics. 
The uninfected children were not afforded the opportunity to access such 
services in their communities.  
 
Collectively, the Psychosocial Functioning (Emotional, Social and School 
Functioning combined) of the children with HIV infection proved significantly 
lower than those in the comparison group (p<0.01). Children with chronic 
diseases have been shown to be more susceptible to psychosocial problems 
(Gannoni and Shute, 2010; Scharko et al, 2006). The possible factors that could 
be affecting the psychosocial functioning and overall lower reported HRQoL in 
this sample of HIV-infected children include: (1) limitations in physical functioning 
could affect the ability of the child to interact effectively with his/her peers; (2) 
living in a household affected by HIV has been shown to have a negative effect 
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on the psychosocial functioning of the child, even if the child is not HIV positive 
(Xu et al, 2010); (3) there was a  significant difference in access to care grants 
(p=0.04), with HIV-infected children more likely to be receiving social support , 
this would indicate an increased vulnerability of the families affected by HIV and 
the consequent socio-economic ramifications. This increased vulnerability may 
be contributing to the psychosocial functioning of the HIV-infected children. When 
controlling for possible covariants - caregiver relationship, caregiver education 
level and care grant status, proved not to be significant covariants with respect to 
Psychosocial Functioning. 
  
The author was unable to compare results from the PedsQL 4.0 Generic Core 
Scale to other research conducted in South Africa. No other literature pertaining 
to HRQoL or QoL in South African children with chronic medical conditions was 
found.The only published data available is for QoL of children, using the PedsQL. 
in children post burns (Weedon and Potterton, 2011). 
 
The disclosure status for the children was unknown and therefore the impact 
thereof and associated stigmatization on psychosocial functioning could not be 
assessed. In a previous study on HIV-positive adolescents in South Africa 
disclosure was associated with a withdrawal from previous social groups and 
activities (Petersen et al, 2010). 
 
Analysis of the relationship of severity of disease (%CD4+) and duration of 
HAART on the HRQoL of the children with HIV (study group) yielded no 
significant pattern. This may be due to various factors including: (1) all of the 
children had a CD4+ count ≥ 25%, indicating no immune-suppression according 
to the CDC classification (Centre for Disease Control, 1994) with no consequent 
negative impact on HRQoL, (2) there was a very limited range of CD4+ 
percentages with little variation and hence a limited effect on HRQoL total scores 
obtained. With respect to HAART, there were only five children in the study group 
with duration of HAART of less than 12 months. The remainder of the children 
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had been receiving HAART for a mean of 35.4 months. With this duration of 
receiving HAART, there may be less number of side–effects that may still be 
impacting on HRQoL.  
 
The impact of viral load on the HRQoL of the HIV–infected children could not be 
studied. In most cases an actual value for viral load was not recorded in the files, 
it was reported as “lowest detectable level”.   
 
It is interesting to note that the children in the comparison group, despite the 
occurrence of a fracture or presence of a contact dermatitis, scored comparably, 
in all four domains, to a group of healthy children used by Varni et al (2001).  
 
 
 
5.4 Limitations of the research 
Limitations in research on HRQoL and QoL are inevitable (Eiser and Morse, 
2001). With reference to this research, the following limitations were noted: 
 The use of a generic HRQoL measurement tool does not allow for the 
evaluation of HRQoL with respect to the impact of a specific disease.  
 Only the child self-report was carried out. The parent-proxy report was not 
performed. 
 Comparison group did not undergo HIV testing, thereby allowing the 
possibility that some of the children could have been HIV positive despite not 
showing any signs of infection. However the children in the comparison group 
were asymptomatic with respect to signs and symptoms relating to HIV 
infection, nor were they on any chronic medication. The researcher hence 
does not feel that the rsults would have differed significantly if comparison 
group did undergo HIV testing. 
 A very narrow age gap was used; therefore these findings may not be 
generalized to other age groups of children.  
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 The PedsQL 4.0 Generic Core Scale has not been validated and normed for 
healthy black South-African children. 
5.5 Relevance to Clinical Practice and Recommendations Based on Results  
The group of HIV-positive Children aged six or seven, beginning their school 
career, reported a lower HRQoL than their peers attending orthopaedic or 
dermatology clinics. Scores in all four domains were significantly lower, indicating 
difficulties with physical and psychosocial functioning (social, emotional and 
school functioning). It is evident that services offered at paediatric HIV clinics 
should not only concentrate on medical management. With the introduction of 
HAART, and HIV becoming a chronic paediatric disease, it has become essential 
to treat the child holistically. The need for a multi-disciplinary approach, meeting 
the medical, social and psychological needs is essential and yet limited to only a 
few regions in the world (Earls et al, 2008). The results of this research indicate 
the need for psychologists, educational psychologists and allied health therapists 
to be involved in the daily care of these children. Ongoing intervention in all 
spheres of functioning may be necessary to ensure a smooth transition into 
adolescence. This intervention should not be based only at the clinics but should 
be extended into the community setting and school environment.  
 
 In addition programmes should be extended to the needs of the caregivers. It 
has been suggested that it is through effective programmes targeting the support 
of caregivers and strengthening the family (economically and psychologically) 
that the negative impact of HIV on children could be to a large extent  lessened  
(Petersen et al, 2010;Chandan and Richter, 2009;Desmond, 2009). It has been 
suggested that all facilities dispensing HAART and treating children with HIV, 
should dedicate at least one day a week to family based intervention (Meyers et 
al, 2007).    
 
5.6 Recommendations for   Future Research 
This research has shown that HIV-infected children report a lower HRQoL. 
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 The creation of a reliable, valid, culturally sensitive and medically 
appropriate questionnaire, for sub-Saharan Africa, needs to be developed. 
The questionnaire should focus both on generic aspects of HRQoL as well 
as the disease specific effects on HRQoL.  
 Correlation of HRQoL and viral load needs to be investigated in this 
paediatric HIV population.  
 Research is required to evaluate the HRQoL of children with CD4+ 
percentages above 25% (indicating immune suppression). The intervention 
services they require might differ to those healthier children infected with 
HIV. 
 A prospective study of HRQoL would be necessary to indicate the changes 
in HRQoL with children moving into adolescence and early adulthood as 
well as with disease progression. 
 Research including a wider age range of children would be beneficial to 
assess the impact of stage of development on HRQoL. 
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Chapter 6: CONCLUSION 
 
In 2008, 1.8 million HIV-infected children were living in sub-Saharan Africa 
(UNAIDS Report, 2009). With the introduction of HAART, HIV has become a 
chronic illness (Garvie et al, 2009). HRQoL has become an important medical 
outcome to consider in children infected with HIV.  The aim of this research was 
to evaluate the HRQoL of 89 children, aged six or seven, attending government 
run clinics. The PedQL4.0 Generic Core Scale, child self-report (ages 5-7) was 
used as the measurement tool. The children were divided into two groups, those 
known to be HIV positive (45) and a comparison group (44). Subjects were well 
matched for age and gender and all were from similar socioeconomic 
backgrounds. 
 
 The PedQL 4.0 Generic Core Scale has been used previously in research 
evaluating the HRQoL of children with HIV. The tool has been found to be 
reliable and valid. For the purposes of this research, the questionnaire was 
translated into Zulu as per translation instructions set out. 
 
The results indicated that HIV-infected children reported a lower HRQoL as 
compared to a comparison group of children. Although all four domains 
(Physical, Emotional, Social and School Functioning) were affected, Physical 
Functioning of the HIV-infected children appeared to be the most compromised. 
This finding supports previous research which found similar findings with respect 
to physical functioning. No relationship could be established between HRQoL 
and CD4+ percentages, viral load or HAART duration. Children with HIV were 
found to be shorter and lighter than those in the comparison group. This 
corresponds to previous research in the literature.  
There is a need for further research to determine the ongoing effect of HIV on the 
HRQoL of children living in South-Africa. Children of different ages and 
developmental capabilities need to be included in the research. This is essential 
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to establish effective interventions to maximize HRQoL which would facilitate the 
effective development of children into adolescents and adults who are able to 
interact effectively with their families, communities and society as a whole. 
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Appendix I    
 
PedsQL 4.0 Generic Core Scale, Child Self- Report 
 
 (Ages 5-7) 
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Appendix II 
 
Scoring of PedsQL 4.0 Generic Core Scale 
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HESSI Questionnaire 
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AN EVALUATION OF THE QUALITY OF LIFE OF CHILDREN WITH 
HIV/AIDS. 
 
 
INFORMATION SHEET FOR THE COMPARISON GROUP  
 
Dear Parent/ caregiver 
 
Hello, my name is Linda Goldberg; I am a physiotherapist working at the Charlotte 
Maxeke Johannesburg Academic Hospital. 
I am doing research to look at the quality of life of children aged six or seven currently 
attending Grade one.   
 
If you agree to participate in the study, I will be asking your child to fill out a short 
questionnaire. The questionnaire is short and will take her fifteen minutes to fill in. The 
questions are short and easy to understand. The questions have been translated into Zulu 
and there is someone to assist you with the questions.  In the questionnaire I will be 
asking her if she can walk, run, play, bathe herself and help in the house.  Other questions 
will be about how she is feeling (sad, angry or worried about anything or having any 
pain). I will be asking her about her friends and how she plays with them, if it is hard to 
make friends. Finally I will be asking her how she is managing with her schoolwork. 
 
 I will also need to ask you a few questions about your household, and your child’s 
health. This questionnaire will take you 5 minutes to complete. There are questions about 
the size of your family, the type of house you live in and your last year that you attended 
school. It will also ask about your income and if anyone is working. The questionnaire is 
in English but we can assist you. 
 
 In addition I will be asking your permission to look at your child’s medical record to get 
information about her orthopaedic treatment in the hospital, her medicine and whether 
she attends any other clinics at the hospital. I will not be using your name or your child’s 
name in the study so that your privacy will be kept at all times. At no time will your child 
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be asked to have any blood tests or painful procedures.  The information I get from you 
will be compared to a separate group of children attending HIV/AIDS outpatient clinic at 
Baragwanath and Charlotte Maxeke Hospital. 
 
 
This study is voluntary and only if you choose to participate you will be included. If at 
any time you choose not to continue in the study, you are free to withdraw. This will have 
no effect on the treatment you get at this clinic. 
 
If you and your child would like to participate in this study please fill in the form below. 
If at any stage you have any questions about this research, please contact me on the 
number 082-5191447. Or you could contact Professor Cleaton-Jones at the Wits Ethics 
Committee at the number 011 717-1234. 
 
Thank you so much 
 
 Linda Goldberg (physiotherapist) 
082 519 1447 
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CONSENT FORM 
 
I __________________________________ agree to participate in the study. My child,  
 
_______________________________________ will also join the study. 
  
 I understand that we can withdraw from the study at any time. 
 
Signed _______________________ 
 
Date ___________________________ 
 
Researcher _________________________ 
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AN EVALUATION OF THE QUALITY OF LIFE OF CHILDREN WITH 
HIV/AIDS 
 
Children’s’ information sheet 
 
Hello, my name is Linda Goldberg. I am a physiotherapist. A physiotherapist is 
someone who works in the hospital with children.  
 
Today I would like to ask you some questions about you.  It will take 15 minutes 
to answer all the questions, but if you don’t want me to ask you the questions – 
you don’t have to. The questions I would like to ask you are about different 
things. The first thing I will be asking you about is how strong you are feeling. Do 
you find it hard to walk, run, play sports, take a bath and help around the home? 
 
The next thing I will be asking you is about your feelings. Do you feel scared, 
sad, angry or worried about anything?  Do you feel any pain anywhere on your 
body? 
 
The third thing I will be asking you is about your friends. Do you have lots of 
friends, do you play nicely with them or do they tease you. 
 
The last thing I will be asking you about is how you are enjoying school. Is it easy 
for you at school; is it hard to remember things? 
 
If you would like to answer the questions, there is someone to help you with the 
questions and your mom can stay with you. Remember, there is nothing that you 
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have to do if you don’t want to. While you are answering the questions, I will be 
looking at your file to get some information about you and your hospital visit. I will 
also have to ask the person you have come to the clinic with some questions 
about your house and the people looking after you.  
 
If you choose not to answer the questions, no one will be cross with you. And if 
you choose to do some and then stop, that is ok.  
Thank you so much  
Linda Goldberg (physiotherapist) 
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CHILD CONSENT FORM 
 
I ____________________________________________ would like to answer the 
questions.  
 
Name _________________________ 
Date ___________________________ 
Researcher _______________________________ 
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AN EVALUATION OF THE QUALITY OF LIFE OF CHILDREN WITH 
HIV/AIDS 
 
CONSENT FORM FOR STUDY GROUP  
 
 
Dear parent/ caregiver 
 
Hello, my name is Linda Goldberg and I am a physiotherapist working at the Charlotte 
Maxeke Johannesburg Academic Hospital. I am doing research at this clinic looking at 
children who are six or seven years old and are in Grade 1 at school. I am trying to find 
out more about your child’s quality of life. I would like to include your child in the study.  
 
 
If you would like to participate in the study, I will be asking your child to fill out a short 
questionnaire. The questionnaire is short and will take her fifteen minutes to fill in. The 
questions are short and easy to understand.  In the questionnaire I will be asking her if she 
can walk, run, play, bathe herself and help in the house.  Other questions will be about 
how she is feeling (sad, angry or worried about anything). I will be asking her about her 
friends and how she plays with them, if it is hard to make friends. Finally I will be asking 
her how she is managing at work and with her schoolwork. Your child will only need to 
do the questionnaire once. 
 
 In addition, I am asking you for your permission to look in your child’s medical file to 
get information on your child’s latest CD4 count and length of time on antiretroviral 
medication. If your child has been on medication for less than 3 months, she will not be 
able to join the study. 
 
I will also need to ask you a few questions about your household, your family and your 
child’s health. This questionnaire will take you 5 minutes to complete. There are 
questions about the size of your family, the type of house you live in and the year you 
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finished school . It will also ask about your income and who is working in the family. 
The questionnaire is in English but we can assist you in translating. 
 
 Your child’s name or your name will not be used in the study, making sure that your 
privacy is kept and there is no disclosure to anyone.  
 
If at any time you choose not to continue with the study, you are free to do so. This will 
have no effect on the treatment you child will get at the clinic. 
 
If you agree to take part in this study please complete the form below. If at any time you 
would like to ask me any questions, please feel free to contact me on 082-5191447. Or 
you can contact Professor Cleaton-Jones  at the Wits Ethics Committee on  the number 
011 717-1234 
 
Thank you so much for your help. 
Linda Goldberg  (physiotherapist) 
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PARENT/CAREGIVER CONSENT 
 
I-____________________________agree that I and my child________________ 
 
Will join this study. I understand that we can withdraw from the study at any time. 
 
Signed_____________ 
 
Date______________ 
 
Researcher_______________________ 
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Appendix VI 
 
Zulu Translation of PedsQL 4.0 Generic Core Scale, Child 
  
Self- Report (Ages 5-7) 
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PedsQL
™
 
Uhlu lwemibuzo ngezinga lempilo 
yezingane 
 
Ihlelo 4.0 
 
UMBIKO WENGANE ENCANE (iminyaka yobudala eyi-5 kuya kweyi-7) 
 
Imiyalelo yomuntu obuza imibuzo: 
 
Ngizokubuza eminye imibuzo ngezinto ezingaba inkinga kwezinye izingane. 
Ngifuna ukwazi ukuthi lezi zinto zingaba inkinga kangakanani kuwe. 
 
Khombisa ingane uhlaka (template) bese ukhomba izimpendulo lapho ufunda. 
 
Uma kungesiyo nhlobo inkinga kuwe, khomba ubuso obumamathekayo. 
Uma kuyinkinga ngezinye izikhathi, khomba ubuso obuphakathi nendawo. 
Uma kuyinkinga kuwe kakhulu, khomba ubuso obuphatheke kabi. 
Ngizofunda umbuzo ngamunye. Khomba ezithombeni ukungibonisa ukuthi 
kuyinkinga kangakanani kuwe. Ake sizame ukukwenza kuqala sibone 
ukuthi kuzokwenzeka yini. 
 
 Akusiyo 
Nhlobo 
Ngezinye 
izikhathi 
Kakhulu 
Kuyinkinga kuwe ukucwayiza    
         
Cela ingane ukuthi ikhombise ukucwayiza ukuze ubone ukuthi umbuzo 
uphendulwe kahle yini. Uphinde umbuzo uma ingane ikhombisa impendulo 
ehlukile kulokhu ekwenzayo. 
ID#: ______________________ 
 
Usuku:____________________ 
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Cabanga ngokuthi ubunjani emasontweni ambalwa edlule. Ngicela ulalele 
umusho ngamunye ngokucophelela bese ungitshela ukuthi kuyinkinga 
kangakanani lokhu kuwe. 
 
Emva kokufunda into, khomba ohlakeni. Uma ingane ingabaza noma ingaqondi 
ukuthi kufanele iphendule kanjani, funda ukhetho lwezimpendulo ngesikhathi 
ukhomba ubuso 
 
Impilo Yakho (izinkinga …) 
Akuyis
o 
Nhlobo 
Ngezinye 
izikhathi 
kakhulu 
1. Ngabe kunzima ukuthi uhambe 0 2 4 
2. Ngabe kunzima ukuthi ugijime 0 2 4 
3. Ngabe kunzima ukuthi udlale imidlalo noma uvocavoce umzimba 0 2 4 
4. Ngabe kunzima ukuthi uphakamise izinto ezinkulu 0 2 4 
5. Ngabe kunzima ukuthi ugeze ebhavini noma eshaweni 0 2 4 
6. Ngabe kunzima ukuthi wenze imisebenzi yasendlini 
(njengokuphakamisa amathoyizi akho) 
0 2 4 
7. Ingabe unakho ukulimala noma ubuhlungu (Kuphi?) 0 2 4 
8. Ngabe uke uzizwe ukhathele kakhulu ukuthi ungadlala 0 2 4 
 
Khumbula, ngitshele ukuthi kube yinkinga kangakanani lokhu kuwe 
emasontweni ambalwa edlule.  
Imizwa Yakho (izinkinga …) 
Akuyis
o 
Nhlobo 
Ngezinye 
izikhathi 
kakhulu 
1. Uzizwa wethukile 0 2 4 
2. Uzizwa uphatheke kabi 0 2 4 
3. Uzizwa uthukuthele 0 2 4 
4. Unenkinga yokulala 0 2 4 
5. Uyakhathazeka ngokuthi yini ezokwenzeka kuwe 0 2 4 
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Abangane Nalabo Ofunda Nabo (izinkinga …) 
Akuyis
o 
Nhlobo 
Ngezinye 
izikhathi 
kakhulu 
1. Kunzima kuwe ukuzwana nezinye izingane 0 2 4 
2. Ziyasho ezinye izingane ukuthi azifuni ukudlala nawe 0 2 4 
3. Ziyakusukela ezinye izingane 0 2 4 
4. Ezinye izingane ziyakwazi ukwenza izinto wena ongakwazi 
ukuzenza 
0 2 4 
5. Kunzima kuwe ukuba sezingeni elifanele lapho udlala nezinye 
izingane 
0 2 4 
 
Ukusebenza Esikoleni (izinkinga …) 
Akuyis
o 
Nhlobo 
Ngezinye 
izikhathi 
kakhulu 
1. Kunzima kuwe ukulalela esikoleni 0 2 4 
2. Uyazikhohlwa izinto 0 2 4 
3. Kunzima kuwe ukuba sezingeni elifanele ngemisebenzi 
yasesikoleni 
0 2 4 
4. Uyaputha esikoleni ngenxa yokungazizwa kahle 0 2 4 
5. Uyaputha esikoleni ngoba kufanele uye kwadokotela noma 
esibhedlela 
0 2 4 
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Kuyinkinga kangakanani lokhu kuwe? 
 
 
 
Akusiyo Nhlobo           Ngezinye izikhathi                Kakhulu 
   
 
 
 
